data_2l6s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2l6s _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 CA--C 1.545 1.029 0 CA-C-O 119.691 -0.212 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -65.79 178.48 2.26 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.855 2.37 . . . . 0.0 112.384 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 68.33 74.02 0.28 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.187 1.395 . . . . 0.0 112.186 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.17 133.73 26.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.794 1.638 . . . . 0.0 112.843 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.92 -49.55 72.18 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.485 0.714 . . . . 0.0 111.255 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -120.71 143.45 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.929 1.691 . . . . 0.0 111.164 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.1 93.82 0.12 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.021 0.82 . . . . 0.0 112.93 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttp . . . . . 0 N--CA 1.479 1.023 0 C-N-CA 123.898 0.879 . . . . 0.0 112.935 174.292 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.542 0.915 0 CA-C-O 119.624 -0.24 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.6 165.16 26.22 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.296 2.664 . . . . 0.0 112.321 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 76.81 73.16 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.47 1.908 . . . . 0.0 112.258 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -150.18 111.6 4.44 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.883 -1.135 . . . . 0.0 113.296 -173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.7 61.45 4.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.061 1.344 . . . . 0.0 111.883 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.65 123.12 24.46 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.165 -0.959 . . . . 0.0 111.389 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.16 27.35 7.79 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.586 2.041 . . . . 0.0 113.536 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.319 1.448 . . . . 0.0 111.444 172.745 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 CA--C 1.542 0.901 0 CA-C-O 118.748 -0.605 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.11 172.82 6.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.39 2.727 . . . . 0.0 113.332 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.79 81.53 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.026 1.73 . . . . 0.0 113.649 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -154.08 140.01 18.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.173 1.389 . . . . 0.0 113.146 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.0 mt -128.37 12.02 6.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.44 1.896 . . . . 0.0 112.96 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.99 156.87 39.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.574 1.95 . . . . 0.0 109.992 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.6 -7.13 9.01 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 125.398 1.479 . . . . 0.0 112.667 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 CA--C 1.544 0.975 0 CA-C-O 119.385 -0.34 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.88 166.74 17.45 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.447 2.765 . . . . 0.0 112.722 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 71.94 69.0 0.15 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.828 2.051 . . . . 0.0 113.471 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -146.92 40.77 1.08 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.469 1.108 . . . . 0.0 113.587 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.35 -170.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 61.1 41.98 13.01 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.92 -34.74 0.41 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.214 -0.929 . . . . 0.0 113.856 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 125.045 1.338 . . . . 0.0 112.472 166.962 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.545 1.026 0 N-CA-C 112.927 0.318 . . . . 0.0 112.927 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.33 162.59 41.79 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.646 2.897 . . . . 0.0 113.506 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 60.59 91.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.774 2.429 . . . . 0.0 114.455 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -153.14 17.45 0.56 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.97 -162.0 0.88 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.254 1.422 . . . . 0.0 111.719 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.53 24.67 5.11 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.88 1.672 . . . . 0.0 113.606 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.09 -103.55 1.77 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.31 1.433 . . . . 0.0 112.35 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 0.0 113.59 177.694 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 CA--C 1.543 0.95 0 N-CA-C 110.794 -0.502 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.12 170.73 17.45 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.883 2.388 . . . . 0.0 112.372 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 68.6 82.44 0.17 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.816 2.046 . . . . 0.0 112.911 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -150.93 136.73 18.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.205 1.002 . . . . 0.0 113.132 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.8 mt -142.5 10.91 1.88 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.666 1.586 . . . . 0.0 112.258 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -161.63 158.85 26.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.553 1.541 . . . . 0.0 110.466 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.62 91.45 0.29 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.92 0.771 . . . . 0.0 112.298 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 128.384 2.674 . . . . 0.0 113.833 178.428 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 CA--C 1.542 0.89 0 CA-C-O 119.334 -0.361 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.92 169.15 13.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.314 2.009 . . . . 0.0 112.05 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 65.02 89.42 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.172 1.789 . . . . 0.0 113.448 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -152.87 -172.23 4.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.441 1.096 . . . . 0.0 112.742 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.23 -165.01 0.11 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.367 1.867 . . . . 0.0 111.589 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.82 -51.9 67.19 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.367 -1.458 . . . . 0.0 112.164 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.27 -49.4 1.23 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.489 1.995 . . . . 0.0 115.422 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.2 mttm . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 129.163 2.985 . . . . 0.0 110.49 -178.217 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 CA--C 1.545 1.071 0 N-CA-C 112.979 0.338 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.69 170.51 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.566 2.177 . . . . 0.0 112.546 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 64.51 75.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.069 1.748 . . . . 0.0 115.011 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -138.87 147.7 42.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.825 1.25 . . . . 0.0 111.963 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.74 170.98 15.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.538 1.135 . . . . 0.0 111.969 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -50.03 156.85 0.7 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.514 1.526 . . . . 0.0 114.415 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.84 -49.41 0.63 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.789 1.185 . . . . 0.0 112.953 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 126.437 1.895 . . . . 0.0 109.944 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.545 1.036 0 CA-C-O 119.278 -0.384 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.18 66.99 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 125.283 3.989 . . . . 0.0 113.253 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.28 37.72 1.9 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.332 1.853 . . . . 0.0 111.518 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.38 148.5 46.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.862 1.265 . . . . 0.0 112.283 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.34 -68.54 0.91 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.374 1.47 . . . . 0.0 109.975 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -87.39 165.93 15.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.421 1.488 . . . . 0.0 112.739 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.64 128.19 2.49 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.175 1.845 . . . . 0.0 110.624 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt . . . . . 0 CA--C 1.55 0.946 0 CA-C-N 117.931 0.865 . . . . 0.0 112.229 179.527 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 CA-C-O 119.029 -0.488 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.4 59.61 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.737 3.625 . . . . 0.0 113.364 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -137.73 46.79 2.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.531 1.933 . . . . 0.0 110.98 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -139.71 124.29 18.25 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.459 1.503 . . . . 0.0 111.518 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.75 -53.87 0.49 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.38 1.472 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.23 -37.81 7.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.05 1.34 . . . . 0.0 112.386 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.27 -10.08 56.11 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.546 0.593 . . . . 0.0 114.432 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 127.555 2.342 . . . . 0.0 111.184 179.374 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.545 1.042 0 CA-C-O 119.618 -0.243 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.47 155.26 71.04 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.555 2.837 . . . . 0.0 113.391 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 61.16 110.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.73 171.85 12.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 111.11 -173.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.465 ' H ' HD12 ' A' ' 13' ' ' LEU . 5.3 mp -49.85 -45.99 50.9 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.285 1.434 . . . . 0.0 114.007 -169.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.06 -59.25 4.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.405 0.682 . . . . 0.0 112.1 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.42 37.7 95.08 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 114.606 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 125.753 1.621 . . . . 0.0 110.446 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.541 0.849 0 CA-C-O 119.171 -0.429 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.3 159.94 49.96 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.126 2.55 . . . . 0.0 113.038 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 72.09 93.56 0.08 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.911 2.485 . . . . 0.0 113.588 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.94 142.65 13.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.694 1.198 . . . . 0.0 113.363 -173.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.4 -56.2 21.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.608 1.163 . . . . 0.0 112.698 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -117.27 -77.15 0.57 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.719 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.08 86.75 0.02 OUTLIER Glycine 0 C--N 1.343 0.968 0 C-N-CA 126.415 1.959 . . . . 0.0 113.99 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 126.259 1.824 . . . . 0.0 112.385 -171.027 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo . . . . . 0 CA--C 1.542 0.912 0 CA-C-O 118.711 -0.62 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.43 64.57 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.787 3.658 . . . . 0.0 113.787 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -134.19 25.8 3.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.806 2.042 . . . . 0.0 112.365 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -129.42 126.07 37.94 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.978 1.311 . . . . 0.0 113.826 -173.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.1 mt -146.59 -27.36 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.763 2.025 . . . . 0.0 113.623 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -117.12 -36.99 3.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.594 1.558 . . . . 0.0 111.304 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.26 -31.11 59.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.123 0.868 . . . . 0.0 113.536 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 125.507 1.523 . . . . 0.0 110.975 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.547 1.165 0 CA-C-O 118.649 -0.646 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.55 58.5 2.51 Favored 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 126.933 5.089 . . . . 0.0 115.145 -169.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.65 24.46 2.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.509 1.923 . . . . 0.0 111.906 -165.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -120.52 140.23 51.76 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.809 1.644 . . . . 0.0 110.167 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.41 -71.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.767 1.227 . . . . 0.0 110.544 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -173.62 164.25 4.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.227 2.211 . . . . 0.0 109.565 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.69 132.49 3.19 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.675 1.607 . . . . 0.0 110.499 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 126.773 2.029 . . . . 0.0 113.701 -174.626 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 123.46 35.5 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.524 0.678 . . . . 0.0 112.01 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.59 88.55 6.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.626 1.57 . . . . 0.0 109.942 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 pt -141.0 155.02 68.94 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.418 1.487 . . . . 0.0 111.37 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.4 176.52 2.65 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.641 2.894 . . . . 0.0 112.796 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -117.0 19.91 14.07 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.774 1.23 . . . . 0.0 112.234 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 t -115.34 153.51 30.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.035 2.534 . . . . 0.0 110.428 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.0 tp -86.46 137.13 34.53 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 111.614 -178.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.97 165.55 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.929 2.419 . . . . 0.0 111.852 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -65.79 178.48 2.26 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.855 2.37 . . . . 0.0 112.384 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 68.33 74.02 0.28 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.187 1.395 . . . . 0.0 112.186 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.17 133.73 26.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.794 1.638 . . . . 0.0 112.843 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.92 -49.55 72.18 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.485 0.714 . . . . 0.0 111.255 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -120.71 143.45 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.929 1.691 . . . . 0.0 111.164 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.1 93.82 0.12 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.021 0.82 . . . . 0.0 112.93 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -58.68 151.63 51.34 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.898 0.879 . . . . 0.0 112.935 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.13 76.55 1.28 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.153 3.902 . . . . 0.0 114.322 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.55 18.94 11.26 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 113.468 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.8 m -143.36 21.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 126.596 1.958 . . . . 0.0 113.348 -172.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--O 1.251 1.18 0 O-C-N 120.327 -1.483 . . . . 0.0 110.678 -178.019 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.78 146.37 35.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.636 -1.29 . . . . 0.0 112.398 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.38 86.37 2.34 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.386 1.474 . . . . 0.0 110.632 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.93 158.94 68.92 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.267 1.827 . . . . 0.0 112.206 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.7 -177.84 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.338 3.359 . . . . 0.0 113.809 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.9 m -50.36 148.67 3.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.173 0.989 . . . . 0.0 112.21 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -58.44 167.85 1.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.674 1.19 . . . . 0.0 113.122 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.3 mt -115.08 80.83 7.28 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.301 1.44 . . . . 0.0 109.324 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.89 165.71 30.21 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.967 3.111 . . . . 0.0 111.481 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.6 165.16 26.22 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.296 2.664 . . . . 0.0 112.321 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 76.81 73.16 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.47 1.908 . . . . 0.0 112.258 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -150.18 111.6 4.44 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.883 -1.135 . . . . 0.0 113.296 -173.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.7 61.45 4.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.061 1.344 . . . . 0.0 111.883 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.65 123.12 24.46 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.165 -0.959 . . . . 0.0 111.389 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.16 27.35 7.79 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.586 2.041 . . . . 0.0 113.536 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -61.37 165.29 7.13 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.319 1.448 . . . . 0.0 111.444 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.37 65.13 3.64 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.481 3.454 . . . . 0.0 112.151 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.31 135.78 11.31 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 111.513 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -147.12 176.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.68 1.992 . . . . 0.0 111.612 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.933 1.693 . . . . 0.0 113.343 174.921 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -134.95 131.81 37.66 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.1 0.96 . . . . 0.0 111.694 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.31 148.3 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 110.633 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.3 pt -145.49 148.46 37.22 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.975 0.91 . . . . 0.0 111.699 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.48 168.73 13.98 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.851 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.38 158.65 4.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.8 0.84 . . . . 0.0 112.394 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 t -65.5 -174.58 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.58 81.03 23.6 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.182 1.393 . . . . 0.0 107.565 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.02 167.03 24.65 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.251 3.3 . . . . 0.0 111.619 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.11 172.82 6.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.39 2.727 . . . . 0.0 113.332 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.79 81.53 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.026 1.73 . . . . 0.0 113.649 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -154.08 140.01 18.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.173 1.389 . . . . 0.0 113.146 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.0 mt -128.37 12.02 6.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.44 1.896 . . . . 0.0 112.96 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.99 156.87 39.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.574 1.95 . . . . 0.0 109.992 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.6 -7.13 9.01 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.0 60.75 11.49 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 125.398 1.479 . . . . 0.0 112.667 -173.389 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.79 170.53 8.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.977 3.118 . . . . 0.0 112.249 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.56 21.22 2.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 112.928 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -98.53 24.52 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.773 1.629 . . . . 0.0 112.934 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.083 1.753 . . . . 0.0 110.845 -175.769 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -79.77 92.67 5.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.911 -1.118 . . . . 0.0 111.813 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.24 106.88 4.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.254 1.022 . . . . 0.0 112.296 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 pt -147.4 74.69 11.58 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.033 1.733 . . . . 0.0 111.107 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.53 172.59 13.1 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.154 2.569 . . . . 0.0 112.832 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.32 142.19 57.73 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.334 -0.854 . . . . 0.0 112.033 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.2 p -156.78 174.52 15.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.773 2.029 . . . . 0.0 111.523 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.37 78.83 4.9 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.842 1.657 . . . . 0.0 109.411 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -66.9 160.13 48.43 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.539 2.159 . . . . 0.0 111.379 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.88 166.74 17.45 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.447 2.765 . . . . 0.0 112.722 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 71.94 69.0 0.15 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.828 2.051 . . . . 0.0 113.471 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -146.92 40.77 1.08 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.469 1.108 . . . . 0.0 113.587 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.35 -170.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 61.1 41.98 13.01 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.92 -34.74 0.41 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.214 -0.929 . . . . 0.0 113.856 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.67 159.83 6.4 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.045 1.338 . . . . 0.0 112.472 166.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -71.7 -166.2 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.06 3.173 . . . . 0.0 112.664 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -53.88 150.44 7.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.854 1.262 . . . . 0.0 113.313 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.14 140.5 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.088 1.355 . . . . 0.0 112.02 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.881 2.073 . . . . 0.0 113.723 -179.149 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -94.55 179.0 5.42 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.163 -1.586 . . . . 0.0 112.015 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.74 117.5 15.59 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.321 -0.862 . . . . 0.0 111.419 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.9 pt -145.84 157.25 51.24 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.689 0.795 . . . . 0.0 112.739 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.76 176.96 6.81 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.111 3.207 . . . . 0.0 113.291 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.7 m -110.61 -0.13 17.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.008 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.9 m -60.5 132.2 53.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.851 1.261 . . . . 0.0 113.295 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.12 152.57 40.07 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.294 1.438 . . . . 0.0 113.102 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.17 169.03 19.1 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.777 2.985 . . . . 0.0 112.927 175.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.33 162.59 41.79 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.646 2.897 . . . . 0.0 113.506 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 60.59 91.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.774 2.429 . . . . 0.0 114.455 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -153.14 17.45 0.56 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.97 -162.0 0.88 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.254 1.422 . . . . 0.0 111.719 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.53 24.67 5.11 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.88 1.672 . . . . 0.0 113.606 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.09 -103.55 1.77 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.31 1.433 . . . . 0.0 112.35 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? 58.58 67.27 2.16 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 0.0 113.59 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 77.06 2.31 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 125.211 3.941 . . . . 0.0 112.813 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 49.79 34.97 8.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.966 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.06 0.88 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.827 1.651 . . . . 0.0 114.152 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.094 1.758 . . . . 0.0 111.434 -175.938 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 44.56 41.24 4.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.446 1.499 . . . . 0.0 113.564 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.37 110.3 8.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.914 2.086 . . . . 0.0 109.414 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -150.3 160.92 32.22 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 127.245 2.218 . . . . 0.0 109.8 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.25 -177.78 3.94 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.471 2.78 . . . . 0.0 112.325 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.8 m 55.64 60.7 3.18 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.124 1.37 . . . . 0.0 113.008 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 t -56.39 132.22 50.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.714 0.806 . . . . 0.0 111.612 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.79 77.98 4.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.394 1.478 . . . . 0.0 108.377 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.23 162.75 40.55 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.578 2.185 . . . . 0.0 110.794 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.12 170.73 17.45 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.883 2.388 . . . . 0.0 112.372 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 68.6 82.44 0.17 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.816 2.046 . . . . 0.0 112.911 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -150.93 136.73 18.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.205 1.002 . . . . 0.0 113.132 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.8 mt -142.5 10.91 1.88 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.666 1.586 . . . . 0.0 112.258 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -161.63 158.85 26.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.553 1.541 . . . . 0.0 110.466 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.62 91.45 0.29 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.92 0.771 . . . . 0.0 112.298 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 76.97 154.15 0.14 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 128.384 2.674 . . . . 0.0 113.833 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.33 173.0 8.12 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.643 2.895 . . . . 0.0 112.214 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -53.13 151.16 5.18 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.11 41.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.124 1.77 . . . . 0.0 111.702 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.269 1.828 . . . . 0.0 112.191 -172.741 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.09 134.32 34.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.739 1.216 . . . . 0.0 111.969 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.5 2.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.407 1.483 . . . . 0.0 111.852 -167.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.46 136.94 19.52 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.657 1.583 . . . . 0.0 109.498 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.49 179.66 3.93 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.204 3.269 . . . . 0.0 112.674 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -154.72 147.19 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.393 0.677 . . . . 0.0 111.814 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -111.53 156.65 21.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.24 1.416 . . . . 0.0 110.367 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.7 pt -55.8 149.88 30.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.662 0.785 . . . . 0.0 112.229 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.92 162.83 20.98 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.657 2.238 . . . . 0.0 111.821 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.92 169.15 13.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.314 2.009 . . . . 0.0 112.05 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 65.02 89.42 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.172 1.789 . . . . 0.0 113.448 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -152.87 -172.23 4.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.441 1.096 . . . . 0.0 112.742 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.0 mp -71.23 -165.01 0.11 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.367 1.867 . . . . 0.0 111.589 177.272 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.82 -51.9 67.19 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.367 -1.458 . . . . 0.0 112.164 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.27 -49.4 1.23 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.489 1.995 . . . . 0.0 115.422 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -158.33 163.72 23.52 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 129.163 2.985 . . . . 0.0 110.49 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.52 -163.03 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.863 3.709 . . . . 0.0 113.003 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -58.49 96.27 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.31 1.444 . . . . 0.0 112.845 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.65 17.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.144 1.778 . . . . 0.0 112.754 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.01 1.724 . . . . 0.0 109.285 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 48.08 37.61 8.23 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.598 1.559 . . . . 0.0 112.784 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.94 92.27 3.64 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 119.896 -1.752 . . . . 0.0 111.411 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.54 162.51 41.6 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.123 2.169 . . . . 0.0 111.625 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.5 -20.48 13.96 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.383 2.722 . . . . 0.0 113.67 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.7 162.27 4.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.869 1.267 . . . . 0.0 112.746 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -137.58 131.74 32.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.143 0.977 . . . . 0.0 110.877 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.01 157.24 52.98 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.708 1.203 . . . . 0.0 112.472 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.71 169.03 15.31 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.64 2.894 . . . . 0.0 112.979 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.69 170.51 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.566 2.177 . . . . 0.0 112.546 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 64.51 75.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.069 1.748 . . . . 0.0 115.011 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -138.87 147.7 42.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.825 1.25 . . . . 0.0 111.963 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.74 170.98 15.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.538 1.135 . . . . 0.0 111.969 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -50.03 156.85 0.7 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.514 1.526 . . . . 0.0 114.415 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.84 -49.41 0.63 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.789 1.185 . . . . 0.0 112.953 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.25 73.32 37.51 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.437 1.895 . . . . 0.0 109.944 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.19 146.62 28.73 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.084 2.523 . . . . 0.0 111.432 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -134.76 115.47 13.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.347 1.459 . . . . 0.0 109.955 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.77 50.88 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.068 1.347 . . . . 0.0 112.202 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.256 1.415 0 CA-C-O 116.354 -1.784 . . . . 0.0 113.474 -175.241 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 69.9 mt . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.14 93.34 3.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.298 1.439 . . . . 0.0 113.263 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.41 67.99 8.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.289 1.435 . . . . 0.0 113.188 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -141.46 163.2 42.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.615 1.966 . . . . 0.0 111.355 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.76 -51.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.264 1.976 . . . . 0.0 112.092 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 p -89.9 110.18 21.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.268 1.427 . . . . 0.0 111.921 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -67.28 174.98 2.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.993 1.317 . . . . 0.0 112.564 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mm 61.25 68.22 1.26 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.586 1.554 . . . . 0.0 111.463 -168.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.21 165.08 27.87 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.619 2.879 . . . . 0.0 112.029 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.18 66.99 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 125.283 3.989 . . . . 0.0 113.253 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.28 37.72 1.9 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.332 1.853 . . . . 0.0 111.518 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.38 148.5 46.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.862 1.265 . . . . 0.0 112.283 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.34 -68.54 0.91 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.374 1.47 . . . . 0.0 109.975 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -87.39 165.93 15.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.421 1.488 . . . . 0.0 112.739 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.64 128.19 2.49 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.175 1.845 . . . . 0.0 110.624 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -60.8 156.01 48.64 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 117.931 0.865 . . . . 0.0 112.229 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.26 88.87 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.032 3.155 . . . . 0.0 112.711 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.79 16.12 3.09 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.776 2.03 . . . . 0.0 112.773 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.95 -177.79 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 126.026 1.73 . . . . 0.0 111.128 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 p90 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 178.64 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.31 20.88 2.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.392 1.477 . . . . 0.0 114.773 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.45 67.98 10.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 111.328 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.26 160.57 56.98 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.165 1.786 . . . . 0.0 111.897 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.53 -172.03 0.35 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 124.276 3.318 . . . . 0.0 112.65 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 p -60.44 -178.58 0.09 Allowed 'General case' 0 CA--C 1.55 0.977 0 O-C-N 121.39 -0.819 . . . . 0.0 113.0 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 t -47.43 142.48 4.16 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.359 1.064 . . . . 0.0 113.512 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.47 74.94 1.22 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.609 1.564 . . . . 0.0 108.962 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.05 168.57 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.231 2.621 . . . . 0.0 111.497 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.4 59.61 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.737 3.625 . . . . 0.0 113.364 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -137.73 46.79 2.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.531 1.933 . . . . 0.0 110.98 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -139.71 124.29 18.25 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.459 1.503 . . . . 0.0 111.518 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.75 -53.87 0.49 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.38 1.472 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.23 -37.81 7.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.05 1.34 . . . . 0.0 112.386 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.27 -10.08 56.11 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.546 0.593 . . . . 0.0 114.432 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -123.99 163.1 37.51 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 127.555 2.342 . . . . 0.0 111.184 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.48 -173.42 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.522 2.815 . . . . 0.0 112.439 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -49.3 123.37 7.34 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.23 1.012 . . . . 0.0 111.603 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -63.11 147.0 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 C--O 1.259 1.558 0 C-N-CA 124.929 1.292 . . . . 0.0 113.951 178.373 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -94.27 150.77 19.98 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.852 0.861 . . . . 0.0 110.894 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.19 126.26 21.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 110.556 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.462 HG21 ' H ' ' A' ' 6' ' ' CYS . 4.0 mp -108.61 130.02 23.26 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.675 1.19 . . . . 0.0 108.156 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.91 -13.44 38.42 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.261 1.974 . . . . 0.0 113.298 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.462 ' H ' HG21 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -95.01 4.63 53.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.683 1.593 . . . . 0.0 114.374 -178.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.4 m -46.93 141.41 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.226 1.01 . . . . 0.0 112.998 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.8 mt 62.71 79.64 0.26 Allowed Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.867 1.267 . . . . 0.0 110.286 -170.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.89 162.37 39.98 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.079 3.186 . . . . 0.0 112.326 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.47 155.26 71.04 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.555 2.837 . . . . 0.0 113.391 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 61.16 110.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.73 171.85 12.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 111.11 -173.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.465 ' H ' HD12 ' A' ' 13' ' ' LEU . 5.3 mp -49.85 -45.99 50.9 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.285 1.434 . . . . 0.0 114.007 -169.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.06 -59.25 4.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.405 0.682 . . . . 0.0 112.1 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.42 37.7 95.08 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 114.606 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.97 75.72 1.6 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 125.753 1.621 . . . . 0.0 110.446 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.9 75.78 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.979 3.119 . . . . 0.0 111.66 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.06 10.64 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.46 1.504 . . . . 0.0 113.442 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.56 44.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.945 2.098 . . . . 0.0 111.97 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--O 1.267 2.005 0 C-N-CA 126.375 1.87 . . . . 0.0 112.601 -173.715 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.75 157.82 45.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.135 1.374 . . . . 0.0 111.195 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.76 108.79 21.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.037 0.935 . . . . 0.0 111.213 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.1 mt 64.64 128.76 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 128.314 2.646 . . . . 0.0 112.94 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.18 -51.29 2.85 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.742 2.295 . . . . 0.0 111.245 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.7 m -57.92 123.67 16.6 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.529 1.132 . . . . 0.0 111.167 172.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -113.3 16.5 19.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.521 1.128 . . . . 0.0 113.09 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.45 157.44 62.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.954 2.102 . . . . 0.0 111.362 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.76 163.18 38.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.216 2.611 . . . . 0.0 111.789 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.3 159.94 49.96 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.126 2.55 . . . . 0.0 113.038 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 72.09 93.56 0.08 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.911 2.485 . . . . 0.0 113.588 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.94 142.65 13.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.694 1.198 . . . . 0.0 113.363 -173.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.4 -56.2 21.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.608 1.163 . . . . 0.0 112.698 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -117.27 -77.15 0.57 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.719 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.08 86.75 0.02 OUTLIER Glycine 0 C--N 1.343 0.968 0 C-N-CA 126.415 1.959 . . . . 0.0 113.99 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt 61.67 171.73 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 126.259 1.824 . . . . 0.0 112.385 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.07 -163.29 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.791 2.327 . . . . 0.0 111.921 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -55.12 -19.86 8.57 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -137.74 -179.51 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 127.002 2.121 . . . . 0.0 110.491 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 C--O 1.256 1.432 0 C-N-CA 125.06 1.344 . . . . 0.0 109.7 178.839 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.977 0.417 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.91 59.18 4.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.788 -1.195 . . . . 0.0 112.538 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.96 101.33 5.2 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.11 -0.994 . . . . 0.0 111.573 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 pt -146.08 153.73 49.57 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.37 1.468 . . . . 0.0 112.809 -175.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.08 -24.03 7.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.039 3.16 . . . . 0.0 113.658 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.4 m -64.81 118.05 8.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.561 0.619 . . . . 0.0 109.92 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -83.81 179.47 7.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.142 1.377 . . . . 0.0 110.378 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.7 mm 52.31 69.33 2.47 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.63 1.172 . . . . 0.0 111.91 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.5 162.49 41.72 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.056 3.171 . . . . 0.0 112.268 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.43 64.57 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.787 3.658 . . . . 0.0 113.787 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -134.19 25.8 3.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.806 2.042 . . . . 0.0 112.365 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -129.42 126.07 37.94 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.978 1.311 . . . . 0.0 113.826 -173.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.1 mt -146.59 -27.36 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.763 2.025 . . . . 0.0 113.623 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -117.12 -36.99 3.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.594 1.558 . . . . 0.0 111.304 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.26 -31.11 59.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.123 0.868 . . . . 0.0 113.536 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 77.75 71.06 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.507 1.523 . . . . 0.0 110.975 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.44 177.52 7.83 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.017 3.144 . . . . 0.0 111.703 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 57.1 64.47 1.62 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.189 1.395 . . . . 0.0 113.563 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.95 -178.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.163 0.985 . . . . 0.0 112.771 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.0 p90 . . . . . 0 C--O 1.256 1.42 0 C-N-CA 127.846 2.458 . . . . 0.0 116.611 177.18 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -77.57 58.31 1.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.418 1.487 . . . . 0.0 112.846 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.2 130.4 19.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.407 1.083 . . . . 0.0 111.558 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.93 152.6 62.52 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.154 1.781 . . . . 0.0 110.129 -174.171 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.1 -32.65 20.86 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.493 2.129 . . . . 0.0 112.279 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.91 169.08 18.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.621 1.568 . . . . 0.0 114.07 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t -102.24 41.11 1.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.978 1.311 . . . . 0.0 112.921 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.5 mm 56.29 67.02 3.01 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.331 1.452 . . . . 0.0 112.112 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.7 160.12 47.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.963 3.109 . . . . 0.0 112.6 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.55 58.5 2.51 Favored 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 126.933 5.089 . . . . 0.0 115.145 -169.488 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.65 24.46 2.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.509 1.923 . . . . 0.0 111.906 -165.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -120.52 140.23 51.76 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.809 1.644 . . . . 0.0 110.167 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.41 -71.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.767 1.227 . . . . 0.0 110.544 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -173.62 164.25 4.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.227 2.211 . . . . 0.0 109.565 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.69 132.49 3.19 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.675 1.607 . . . . 0.0 110.499 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.68 69.27 0.69 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.773 2.029 . . . . 0.0 113.701 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.66 89.56 0.51 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.635 2.89 . . . . 0.0 111.35 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -120.23 23.92 10.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.871 1.668 . . . . 0.0 112.085 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.92 -178.54 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 128.072 2.549 . . . . 0.0 109.12 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.473 1.909 . . . . 0.0 115.622 179.24 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 CA--C 1.545 1.029 0 CA-C-O 119.691 -0.212 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -65.79 178.48 2.26 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.855 2.37 . . . . 0.0 112.384 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 68.33 74.02 0.28 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.187 1.395 . . . . 0.0 112.186 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.17 133.73 26.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.794 1.638 . . . . 0.0 112.843 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.92 -49.55 72.18 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.485 0.714 . . . . 0.0 111.255 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -120.71 143.45 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.929 1.691 . . . . 0.0 111.164 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.1 93.82 0.12 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.021 0.82 . . . . 0.0 112.93 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttp . . . . . 0 N--CA 1.479 1.023 0 C-N-CA 123.898 0.879 . . . . 0.0 112.935 174.292 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.542 0.915 0 CA-C-O 119.624 -0.24 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.6 165.16 26.22 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.296 2.664 . . . . 0.0 112.321 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 76.81 73.16 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.47 1.908 . . . . 0.0 112.258 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -150.18 111.6 4.44 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.883 -1.135 . . . . 0.0 113.296 -173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.7 61.45 4.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.061 1.344 . . . . 0.0 111.883 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.65 123.12 24.46 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.165 -0.959 . . . . 0.0 111.389 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.16 27.35 7.79 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.586 2.041 . . . . 0.0 113.536 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.319 1.448 . . . . 0.0 111.444 172.745 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 CA--C 1.542 0.901 0 CA-C-O 118.748 -0.605 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.11 172.82 6.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.39 2.727 . . . . 0.0 113.332 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.79 81.53 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.026 1.73 . . . . 0.0 113.649 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -154.08 140.01 18.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.173 1.389 . . . . 0.0 113.146 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.0 mt -128.37 12.02 6.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.44 1.896 . . . . 0.0 112.96 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.99 156.87 39.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.574 1.95 . . . . 0.0 109.992 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.6 -7.13 9.01 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 125.398 1.479 . . . . 0.0 112.667 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 CA--C 1.544 0.975 0 CA-C-O 119.385 -0.34 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.88 166.74 17.45 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.447 2.765 . . . . 0.0 112.722 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 71.94 69.0 0.15 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.828 2.051 . . . . 0.0 113.471 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -146.92 40.77 1.08 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.469 1.108 . . . . 0.0 113.587 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.35 -170.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 61.1 41.98 13.01 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.92 -34.74 0.41 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.214 -0.929 . . . . 0.0 113.856 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 125.045 1.338 . . . . 0.0 112.472 166.962 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.545 1.026 0 N-CA-C 112.927 0.318 . . . . 0.0 112.927 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.33 162.59 41.79 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.646 2.897 . . . . 0.0 113.506 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 60.59 91.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.774 2.429 . . . . 0.0 114.455 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -153.14 17.45 0.56 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.97 -162.0 0.88 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.254 1.422 . . . . 0.0 111.719 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.53 24.67 5.11 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.88 1.672 . . . . 0.0 113.606 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.09 -103.55 1.77 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.31 1.433 . . . . 0.0 112.35 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 0.0 113.59 177.694 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 CA--C 1.543 0.95 0 N-CA-C 110.794 -0.502 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.12 170.73 17.45 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.883 2.388 . . . . 0.0 112.372 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 68.6 82.44 0.17 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.816 2.046 . . . . 0.0 112.911 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -150.93 136.73 18.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.205 1.002 . . . . 0.0 113.132 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.8 mt -142.5 10.91 1.88 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.666 1.586 . . . . 0.0 112.258 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -161.63 158.85 26.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.553 1.541 . . . . 0.0 110.466 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.62 91.45 0.29 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.92 0.771 . . . . 0.0 112.298 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 128.384 2.674 . . . . 0.0 113.833 178.428 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 CA--C 1.542 0.89 0 CA-C-O 119.334 -0.361 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.92 169.15 13.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.314 2.009 . . . . 0.0 112.05 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 65.02 89.42 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.172 1.789 . . . . 0.0 113.448 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -152.87 -172.23 4.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.441 1.096 . . . . 0.0 112.742 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 13' ' ' LEU . 3.0 mp -71.23 -165.01 0.11 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.367 1.867 . . . . 0.0 111.589 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.82 -51.9 67.19 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.367 -1.458 . . . . 0.0 112.164 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.27 -49.4 1.23 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.489 1.995 . . . . 0.0 115.422 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.2 mttm . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 129.163 2.985 . . . . 0.0 110.49 -178.217 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 CA--C 1.545 1.071 0 N-CA-C 112.979 0.338 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.69 170.51 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.566 2.177 . . . . 0.0 112.546 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 64.51 75.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.069 1.748 . . . . 0.0 115.011 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -138.87 147.7 42.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.825 1.25 . . . . 0.0 111.963 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.74 170.98 15.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.538 1.135 . . . . 0.0 111.969 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -50.03 156.85 0.7 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.514 1.526 . . . . 0.0 114.415 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.84 -49.41 0.63 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.789 1.185 . . . . 0.0 112.953 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 126.437 1.895 . . . . 0.0 109.944 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.545 1.036 0 CA-C-O 119.278 -0.384 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.18 66.99 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 125.283 3.989 . . . . 0.0 113.253 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.28 37.72 1.9 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.332 1.853 . . . . 0.0 111.518 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.38 148.5 46.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.862 1.265 . . . . 0.0 112.283 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.34 -68.54 0.91 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.374 1.47 . . . . 0.0 109.975 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -87.39 165.93 15.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.421 1.488 . . . . 0.0 112.739 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.64 128.19 2.49 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.175 1.845 . . . . 0.0 110.624 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt . . . . . 0 CA--C 1.55 0.946 0 CA-C-N 117.931 0.865 . . . . 0.0 112.229 179.527 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 CA-C-O 119.029 -0.488 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.4 59.61 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.737 3.625 . . . . 0.0 113.364 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -137.73 46.79 2.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.531 1.933 . . . . 0.0 110.98 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -139.71 124.29 18.25 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.459 1.503 . . . . 0.0 111.518 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.75 -53.87 0.49 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.38 1.472 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.23 -37.81 7.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.05 1.34 . . . . 0.0 112.386 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.27 -10.08 56.11 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.546 0.593 . . . . 0.0 114.432 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 127.555 2.342 . . . . 0.0 111.184 179.374 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.545 1.042 0 CA-C-O 119.618 -0.243 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.47 155.26 71.04 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.555 2.837 . . . . 0.0 113.391 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 61.16 110.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.73 171.85 12.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 111.11 -173.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 13' ' ' LEU . 5.3 mp -49.85 -45.99 50.9 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.285 1.434 . . . . 0.0 114.007 -169.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.06 -59.25 4.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.405 0.682 . . . . 0.0 112.1 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.42 37.7 95.08 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 114.606 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 125.753 1.621 . . . . 0.0 110.446 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.541 0.849 0 CA-C-O 119.171 -0.429 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.3 159.94 49.96 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.126 2.55 . . . . 0.0 113.038 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 72.09 93.56 0.08 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.911 2.485 . . . . 0.0 113.588 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.94 142.65 13.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.694 1.198 . . . . 0.0 113.363 -173.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.4 -56.2 21.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.608 1.163 . . . . 0.0 112.698 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -117.27 -77.15 0.57 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.719 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.08 86.75 0.02 OUTLIER Glycine 0 C--N 1.343 0.968 0 C-N-CA 126.415 1.959 . . . . 0.0 113.99 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 126.259 1.824 . . . . 0.0 112.385 -171.027 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo . . . . . 0 CA--C 1.542 0.912 0 CA-C-O 118.711 -0.62 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.43 64.57 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.787 3.658 . . . . 0.0 113.787 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -134.19 25.8 3.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.806 2.042 . . . . 0.0 112.365 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -129.42 126.07 37.94 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.978 1.311 . . . . 0.0 113.826 -173.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.1 mt -146.59 -27.36 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.763 2.025 . . . . 0.0 113.623 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -117.12 -36.99 3.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.594 1.558 . . . . 0.0 111.304 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.26 -31.11 59.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.123 0.868 . . . . 0.0 113.536 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 125.507 1.523 . . . . 0.0 110.975 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.547 1.165 0 CA-C-O 118.649 -0.646 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.55 58.5 2.51 Favored 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 126.933 5.089 . . . . 0.0 115.145 -169.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.65 24.46 2.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.509 1.923 . . . . 0.0 111.906 -165.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -120.52 140.23 51.76 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.809 1.644 . . . . 0.0 110.167 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.41 -71.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.767 1.227 . . . . 0.0 110.544 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -173.62 164.25 4.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.227 2.211 . . . . 0.0 109.565 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.69 132.49 3.19 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.675 1.607 . . . . 0.0 110.499 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 126.773 2.029 . . . . 0.0 113.701 -174.626 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 123.46 35.5 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.524 0.678 . . . . 0.0 112.01 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.59 88.55 6.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.626 1.57 . . . . 0.0 109.942 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 pt -141.0 155.02 68.94 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.418 1.487 . . . . 0.0 111.37 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.4 176.52 2.65 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.641 2.894 . . . . 0.0 112.796 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -117.0 19.91 14.07 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.774 1.23 . . . . 0.0 112.234 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 t -115.34 153.51 30.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.035 2.534 . . . . 0.0 110.428 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 HG21 ' A' ' 19' ' ' VAL . 8.0 tp -86.46 137.13 34.53 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 111.614 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.97 165.55 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.929 2.419 . . . . 0.0 111.852 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -65.79 178.48 2.26 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.855 2.37 . . . . 0.0 112.384 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 68.33 74.02 0.28 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.187 1.395 . . . . 0.0 112.186 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.17 133.73 26.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.794 1.638 . . . . 0.0 112.843 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.92 -49.55 72.18 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.485 0.714 . . . . 0.0 111.255 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -120.71 143.45 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.929 1.691 . . . . 0.0 111.164 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.1 93.82 0.12 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.021 0.82 . . . . 0.0 112.93 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -58.68 151.63 51.34 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.898 0.879 . . . . 0.0 112.935 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.13 76.55 1.28 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.153 3.902 . . . . 0.0 114.322 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.55 18.94 11.26 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 113.468 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 HG22 ' A' ' 8' ' ' ILE . 15.8 m -143.36 21.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 126.596 1.958 . . . . 0.0 113.348 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--O 1.251 1.18 0 O-C-N 120.327 -1.483 . . . . 0.0 110.678 -178.019 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.78 146.37 35.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.636 -1.29 . . . . 0.0 112.398 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.38 86.37 2.34 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.386 1.474 . . . . 0.0 110.632 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.93 158.94 68.92 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.267 1.827 . . . . 0.0 112.206 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.7 -177.84 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.338 3.359 . . . . 0.0 113.809 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.9 m -50.36 148.67 3.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.173 0.989 . . . . 0.0 112.21 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -58.44 167.85 1.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.674 1.19 . . . . 0.0 113.122 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.3 mt -115.08 80.83 7.28 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.301 1.44 . . . . 0.0 109.324 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.89 165.71 30.21 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.967 3.111 . . . . 0.0 111.481 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.6 165.16 26.22 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.296 2.664 . . . . 0.0 112.321 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 76.81 73.16 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.47 1.908 . . . . 0.0 112.258 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -150.18 111.6 4.44 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.883 -1.135 . . . . 0.0 113.296 -173.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.7 61.45 4.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.061 1.344 . . . . 0.0 111.883 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.65 123.12 24.46 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.165 -0.959 . . . . 0.0 111.389 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.16 27.35 7.79 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.586 2.041 . . . . 0.0 113.536 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -61.37 165.29 7.13 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.319 1.448 . . . . 0.0 111.444 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.37 65.13 3.64 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.481 3.454 . . . . 0.0 112.151 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.31 135.78 11.31 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 111.513 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -147.12 176.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.68 1.992 . . . . 0.0 111.612 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.933 1.693 . . . . 0.0 113.343 174.921 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -134.95 131.81 37.66 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.1 0.96 . . . . 0.0 111.694 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.31 148.3 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 110.633 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.3 pt -145.49 148.46 37.22 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.975 0.91 . . . . 0.0 111.699 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.48 168.73 13.98 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.851 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.38 158.65 4.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.8 0.84 . . . . 0.0 112.394 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 t -65.5 -174.58 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.58 81.03 23.6 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.182 1.393 . . . . 0.0 107.565 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.02 167.03 24.65 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.251 3.3 . . . . 0.0 111.619 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.11 172.82 6.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.39 2.727 . . . . 0.0 113.332 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.79 81.53 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.026 1.73 . . . . 0.0 113.649 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -154.08 140.01 18.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.173 1.389 . . . . 0.0 113.146 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.0 mt -128.37 12.02 6.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.44 1.896 . . . . 0.0 112.96 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.99 156.87 39.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.574 1.95 . . . . 0.0 109.992 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.6 -7.13 9.01 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.0 60.75 11.49 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 125.398 1.479 . . . . 0.0 112.667 -173.389 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.79 170.53 8.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.977 3.118 . . . . 0.0 112.249 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.56 21.22 2.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 112.928 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -98.53 24.52 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.773 1.629 . . . . 0.0 112.934 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.083 1.753 . . . . 0.0 110.845 -175.769 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -79.77 92.67 5.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.911 -1.118 . . . . 0.0 111.813 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.24 106.88 4.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.254 1.022 . . . . 0.0 112.296 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 pt -147.4 74.69 11.58 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.033 1.733 . . . . 0.0 111.107 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.53 172.59 13.1 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.154 2.569 . . . . 0.0 112.832 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.32 142.19 57.73 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.334 -0.854 . . . . 0.0 112.033 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.2 p -156.78 174.52 15.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.773 2.029 . . . . 0.0 111.523 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.37 78.83 4.9 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.842 1.657 . . . . 0.0 109.411 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -66.9 160.13 48.43 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.539 2.159 . . . . 0.0 111.379 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.88 166.74 17.45 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.447 2.765 . . . . 0.0 112.722 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 71.94 69.0 0.15 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.828 2.051 . . . . 0.0 113.471 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -146.92 40.77 1.08 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.469 1.108 . . . . 0.0 113.587 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.35 -170.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 61.1 41.98 13.01 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.92 -34.74 0.41 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.214 -0.929 . . . . 0.0 113.856 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.67 159.83 6.4 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.045 1.338 . . . . 0.0 112.472 166.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -71.7 -166.2 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.06 3.173 . . . . 0.0 112.664 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -53.88 150.44 7.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.854 1.262 . . . . 0.0 113.313 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.14 140.5 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.088 1.355 . . . . 0.0 112.02 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.881 2.073 . . . . 0.0 113.723 -179.149 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -94.55 179.0 5.42 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.163 -1.586 . . . . 0.0 112.015 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.74 117.5 15.59 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.321 -0.862 . . . . 0.0 111.419 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.9 pt -145.84 157.25 51.24 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.689 0.795 . . . . 0.0 112.739 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.76 176.96 6.81 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.111 3.207 . . . . 0.0 113.291 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.7 m -110.61 -0.13 17.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.008 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.9 m -60.5 132.2 53.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.851 1.261 . . . . 0.0 113.295 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.12 152.57 40.07 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.294 1.438 . . . . 0.0 113.102 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.17 169.03 19.1 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.777 2.985 . . . . 0.0 112.927 175.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.33 162.59 41.79 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.646 2.897 . . . . 0.0 113.506 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 60.59 91.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.774 2.429 . . . . 0.0 114.455 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -153.14 17.45 0.56 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.97 -162.0 0.88 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.254 1.422 . . . . 0.0 111.719 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.53 24.67 5.11 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.88 1.672 . . . . 0.0 113.606 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.09 -103.55 1.77 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.31 1.433 . . . . 0.0 112.35 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? 58.58 67.27 2.16 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 0.0 113.59 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 77.06 2.31 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 125.211 3.941 . . . . 0.0 112.813 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 49.79 34.97 8.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.966 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.06 0.88 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.827 1.651 . . . . 0.0 114.152 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.094 1.758 . . . . 0.0 111.434 -175.938 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 44.56 41.24 4.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.446 1.499 . . . . 0.0 113.564 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.37 110.3 8.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.914 2.086 . . . . 0.0 109.414 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -150.3 160.92 32.22 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 127.245 2.218 . . . . 0.0 109.8 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.25 -177.78 3.94 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.471 2.78 . . . . 0.0 112.325 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.8 m 55.64 60.7 3.18 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.124 1.37 . . . . 0.0 113.008 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 t -56.39 132.22 50.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.714 0.806 . . . . 0.0 111.612 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.79 77.98 4.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.394 1.478 . . . . 0.0 108.377 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.23 162.75 40.55 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.578 2.185 . . . . 0.0 110.794 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.12 170.73 17.45 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.883 2.388 . . . . 0.0 112.372 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 68.6 82.44 0.17 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.816 2.046 . . . . 0.0 112.911 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -150.93 136.73 18.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.205 1.002 . . . . 0.0 113.132 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.8 mt -142.5 10.91 1.88 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.666 1.586 . . . . 0.0 112.258 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -161.63 158.85 26.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.553 1.541 . . . . 0.0 110.466 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.62 91.45 0.29 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.92 0.771 . . . . 0.0 112.298 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 76.97 154.15 0.14 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 128.384 2.674 . . . . 0.0 113.833 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.33 173.0 8.12 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.643 2.895 . . . . 0.0 112.214 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -53.13 151.16 5.18 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.11 41.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.124 1.77 . . . . 0.0 111.702 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.269 1.828 . . . . 0.0 112.191 -172.741 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.09 134.32 34.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.739 1.216 . . . . 0.0 111.969 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.5 2.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.407 1.483 . . . . 0.0 111.852 -167.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.46 136.94 19.52 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.657 1.583 . . . . 0.0 109.498 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.49 179.66 3.93 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.204 3.269 . . . . 0.0 112.674 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -154.72 147.19 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.393 0.677 . . . . 0.0 111.814 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -111.53 156.65 21.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.24 1.416 . . . . 0.0 110.367 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.7 pt -55.8 149.88 30.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.662 0.785 . . . . 0.0 112.229 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.92 162.83 20.98 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.657 2.238 . . . . 0.0 111.821 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.92 169.15 13.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.314 2.009 . . . . 0.0 112.05 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 65.02 89.42 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.172 1.789 . . . . 0.0 113.448 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -152.87 -172.23 4.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.441 1.096 . . . . 0.0 112.742 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.482 HD12 ' H ' ' A' ' 13' ' ' LEU . 3.0 mp -71.23 -165.01 0.11 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.367 1.867 . . . . 0.0 111.589 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.82 -51.9 67.19 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.367 -1.458 . . . . 0.0 112.164 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.27 -49.4 1.23 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.489 1.995 . . . . 0.0 115.422 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -158.33 163.72 23.52 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 129.163 2.985 . . . . 0.0 110.49 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.52 -163.03 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.863 3.709 . . . . 0.0 113.003 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -58.49 96.27 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.31 1.444 . . . . 0.0 112.845 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.65 17.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.144 1.778 . . . . 0.0 112.754 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.01 1.724 . . . . 0.0 109.285 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 48.08 37.61 8.23 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.598 1.559 . . . . 0.0 112.784 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.94 92.27 3.64 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 119.896 -1.752 . . . . 0.0 111.411 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.54 162.51 41.6 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.123 2.169 . . . . 0.0 111.625 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.5 -20.48 13.96 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.383 2.722 . . . . 0.0 113.67 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.7 162.27 4.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.869 1.267 . . . . 0.0 112.746 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -137.58 131.74 32.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.143 0.977 . . . . 0.0 110.877 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.01 157.24 52.98 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.708 1.203 . . . . 0.0 112.472 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.71 169.03 15.31 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.64 2.894 . . . . 0.0 112.979 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.69 170.51 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.566 2.177 . . . . 0.0 112.546 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 64.51 75.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.069 1.748 . . . . 0.0 115.011 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -138.87 147.7 42.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.825 1.25 . . . . 0.0 111.963 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.74 170.98 15.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.538 1.135 . . . . 0.0 111.969 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -50.03 156.85 0.7 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.514 1.526 . . . . 0.0 114.415 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.84 -49.41 0.63 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.789 1.185 . . . . 0.0 112.953 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.25 73.32 37.51 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.437 1.895 . . . . 0.0 109.944 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.19 146.62 28.73 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.084 2.523 . . . . 0.0 111.432 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -134.76 115.47 13.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.347 1.459 . . . . 0.0 109.955 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.77 50.88 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.068 1.347 . . . . 0.0 112.202 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.256 1.415 0 CA-C-O 116.354 -1.784 . . . . 0.0 113.474 -175.241 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 69.9 mt . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.14 93.34 3.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.298 1.439 . . . . 0.0 113.263 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.41 67.99 8.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.289 1.435 . . . . 0.0 113.188 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -141.46 163.2 42.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.615 1.966 . . . . 0.0 111.355 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.76 -51.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.264 1.976 . . . . 0.0 112.092 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 p -89.9 110.18 21.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.268 1.427 . . . . 0.0 111.921 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -67.28 174.98 2.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.993 1.317 . . . . 0.0 112.564 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mm 61.25 68.22 1.26 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.586 1.554 . . . . 0.0 111.463 -168.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.21 165.08 27.87 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.619 2.879 . . . . 0.0 112.029 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.18 66.99 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 125.283 3.989 . . . . 0.0 113.253 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.28 37.72 1.9 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.332 1.853 . . . . 0.0 111.518 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.38 148.5 46.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.862 1.265 . . . . 0.0 112.283 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.34 -68.54 0.91 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.374 1.47 . . . . 0.0 109.975 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -87.39 165.93 15.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.421 1.488 . . . . 0.0 112.739 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.64 128.19 2.49 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.175 1.845 . . . . 0.0 110.624 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -60.8 156.01 48.64 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 117.931 0.865 . . . . 0.0 112.229 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.26 88.87 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.032 3.155 . . . . 0.0 112.711 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.79 16.12 3.09 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.776 2.03 . . . . 0.0 112.773 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.95 -177.79 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 126.026 1.73 . . . . 0.0 111.128 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 p90 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 178.64 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.31 20.88 2.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.392 1.477 . . . . 0.0 114.773 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.45 67.98 10.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 111.328 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.26 160.57 56.98 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.165 1.786 . . . . 0.0 111.897 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.53 -172.03 0.35 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 124.276 3.318 . . . . 0.0 112.65 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 p -60.44 -178.58 0.09 Allowed 'General case' 0 CA--C 1.55 0.977 0 O-C-N 121.39 -0.819 . . . . 0.0 113.0 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 t -47.43 142.48 4.16 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.359 1.064 . . . . 0.0 113.512 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.47 74.94 1.22 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.609 1.564 . . . . 0.0 108.962 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.05 168.57 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.231 2.621 . . . . 0.0 111.497 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.4 59.61 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.737 3.625 . . . . 0.0 113.364 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -137.73 46.79 2.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.531 1.933 . . . . 0.0 110.98 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -139.71 124.29 18.25 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.459 1.503 . . . . 0.0 111.518 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.75 -53.87 0.49 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.38 1.472 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.23 -37.81 7.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.05 1.34 . . . . 0.0 112.386 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.27 -10.08 56.11 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.546 0.593 . . . . 0.0 114.432 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -123.99 163.1 37.51 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 127.555 2.342 . . . . 0.0 111.184 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.48 -173.42 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.522 2.815 . . . . 0.0 112.439 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -49.3 123.37 7.34 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.23 1.012 . . . . 0.0 111.603 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -63.11 147.0 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 C--O 1.259 1.558 0 C-N-CA 124.929 1.292 . . . . 0.0 113.951 178.373 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -94.27 150.77 19.98 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.852 0.861 . . . . 0.0 110.894 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.19 126.26 21.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 110.556 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 6' ' ' CYS . 4.0 mp -108.61 130.02 23.26 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.675 1.19 . . . . 0.0 108.156 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.91 -13.44 38.42 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.261 1.974 . . . . 0.0 113.298 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.526 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -95.01 4.63 53.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.683 1.593 . . . . 0.0 114.374 -178.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.4 m -46.93 141.41 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.226 1.01 . . . . 0.0 112.998 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.8 mt 62.71 79.64 0.26 Allowed Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.867 1.267 . . . . 0.0 110.286 -170.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.89 162.37 39.98 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.079 3.186 . . . . 0.0 112.326 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.47 155.26 71.04 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.555 2.837 . . . . 0.0 113.391 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 61.16 110.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.73 171.85 12.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 111.11 -173.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.596 HD12 ' H ' ' A' ' 13' ' ' LEU . 5.3 mp -49.85 -45.99 50.9 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.285 1.434 . . . . 0.0 114.007 -169.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.06 -59.25 4.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.405 0.682 . . . . 0.0 112.1 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.42 37.7 95.08 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 114.606 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.97 75.72 1.6 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 125.753 1.621 . . . . 0.0 110.446 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.9 75.78 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.979 3.119 . . . . 0.0 111.66 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.06 10.64 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.46 1.504 . . . . 0.0 113.442 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.56 44.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.945 2.098 . . . . 0.0 111.97 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--O 1.267 2.005 0 C-N-CA 126.375 1.87 . . . . 0.0 112.601 -173.715 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 1' ' ' LEU . 4.5 mm? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.75 157.82 45.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.135 1.374 . . . . 0.0 111.195 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.76 108.79 21.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.037 0.935 . . . . 0.0 111.213 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.1 mt 64.64 128.76 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 128.314 2.646 . . . . 0.0 112.94 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.18 -51.29 2.85 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.742 2.295 . . . . 0.0 111.245 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.7 m -57.92 123.67 16.6 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.529 1.132 . . . . 0.0 111.167 172.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -113.3 16.5 19.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.521 1.128 . . . . 0.0 113.09 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.45 157.44 62.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.954 2.102 . . . . 0.0 111.362 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.76 163.18 38.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.216 2.611 . . . . 0.0 111.789 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.3 159.94 49.96 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.126 2.55 . . . . 0.0 113.038 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 72.09 93.56 0.08 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.911 2.485 . . . . 0.0 113.588 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.94 142.65 13.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.694 1.198 . . . . 0.0 113.363 -173.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.4 -56.2 21.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.608 1.163 . . . . 0.0 112.698 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -117.27 -77.15 0.57 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.719 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.08 86.75 0.02 OUTLIER Glycine 0 C--N 1.343 0.968 0 C-N-CA 126.415 1.959 . . . . 0.0 113.99 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt 61.67 171.73 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 126.259 1.824 . . . . 0.0 112.385 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.07 -163.29 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.791 2.327 . . . . 0.0 111.921 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -55.12 -19.86 8.57 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -137.74 -179.51 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 127.002 2.121 . . . . 0.0 110.491 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 C--O 1.256 1.432 0 C-N-CA 125.06 1.344 . . . . 0.0 109.7 178.839 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.977 0.417 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.91 59.18 4.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.788 -1.195 . . . . 0.0 112.538 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.96 101.33 5.2 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.11 -0.994 . . . . 0.0 111.573 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 pt -146.08 153.73 49.57 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.37 1.468 . . . . 0.0 112.809 -175.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.08 -24.03 7.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.039 3.16 . . . . 0.0 113.658 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.4 m -64.81 118.05 8.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.561 0.619 . . . . 0.0 109.92 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -83.81 179.47 7.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.142 1.377 . . . . 0.0 110.378 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.7 mm 52.31 69.33 2.47 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.63 1.172 . . . . 0.0 111.91 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.5 162.49 41.72 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.056 3.171 . . . . 0.0 112.268 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.43 64.57 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.787 3.658 . . . . 0.0 113.787 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -134.19 25.8 3.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.806 2.042 . . . . 0.0 112.365 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -129.42 126.07 37.94 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.978 1.311 . . . . 0.0 113.826 -173.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.1 mt -146.59 -27.36 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.763 2.025 . . . . 0.0 113.623 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -117.12 -36.99 3.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.594 1.558 . . . . 0.0 111.304 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.26 -31.11 59.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.123 0.868 . . . . 0.0 113.536 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 77.75 71.06 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.507 1.523 . . . . 0.0 110.975 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.44 177.52 7.83 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.017 3.144 . . . . 0.0 111.703 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 57.1 64.47 1.62 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.189 1.395 . . . . 0.0 113.563 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.95 -178.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.163 0.985 . . . . 0.0 112.771 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.0 p90 . . . . . 0 C--O 1.256 1.42 0 C-N-CA 127.846 2.458 . . . . 0.0 116.611 177.18 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -77.57 58.31 1.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.418 1.487 . . . . 0.0 112.846 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.2 130.4 19.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.407 1.083 . . . . 0.0 111.558 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.93 152.6 62.52 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.154 1.781 . . . . 0.0 110.129 -174.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.1 -32.65 20.86 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.493 2.129 . . . . 0.0 112.279 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.91 169.08 18.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.621 1.568 . . . . 0.0 114.07 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t -102.24 41.11 1.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.978 1.311 . . . . 0.0 112.921 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.5 mm 56.29 67.02 3.01 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.331 1.452 . . . . 0.0 112.112 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.7 160.12 47.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.963 3.109 . . . . 0.0 112.6 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.55 58.5 2.51 Favored 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 126.933 5.089 . . . . 0.0 115.145 -169.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.65 24.46 2.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.509 1.923 . . . . 0.0 111.906 -165.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -120.52 140.23 51.76 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.809 1.644 . . . . 0.0 110.167 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.41 -71.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.767 1.227 . . . . 0.0 110.544 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -173.62 164.25 4.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.227 2.211 . . . . 0.0 109.565 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.69 132.49 3.19 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.675 1.607 . . . . 0.0 110.499 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.68 69.27 0.69 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.773 2.029 . . . . 0.0 113.701 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.66 89.56 0.51 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.635 2.89 . . . . 0.0 111.35 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -120.23 23.92 10.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.871 1.668 . . . . 0.0 112.085 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.92 -178.54 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 128.072 2.549 . . . . 0.0 109.12 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.473 1.909 . . . . 0.0 115.622 179.24 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 CA--C 1.545 1.029 0 CA-C-O 119.691 -0.212 . . . . 0.0 111.852 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -65.79 178.48 2.26 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.855 2.37 . . . . 0.0 112.384 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 68.33 74.02 0.28 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.187 1.395 . . . . 0.0 112.186 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.17 133.73 26.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.794 1.638 . . . . 0.0 112.843 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.92 -49.55 72.18 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.485 0.714 . . . . 0.0 111.255 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -120.71 143.45 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.929 1.691 . . . . 0.0 111.164 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.1 93.82 0.12 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.021 0.82 . . . . 0.0 112.93 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttp . . . . . 0 N--CA 1.479 1.023 0 C-N-CA 123.898 0.879 . . . . 0.0 112.935 174.292 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo . . . . . 0 CA--C 1.542 0.915 0 CA-C-O 119.624 -0.24 . . . . 0.0 111.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.6 165.16 26.22 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.296 2.664 . . . . 0.0 112.321 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 76.81 73.16 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.47 1.908 . . . . 0.0 112.258 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -150.18 111.6 4.44 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.883 -1.135 . . . . 0.0 113.296 -173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.7 61.45 4.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.061 1.344 . . . . 0.0 111.883 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.65 123.12 24.46 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.165 -0.959 . . . . 0.0 111.389 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.16 27.35 7.79 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.586 2.041 . . . . 0.0 113.536 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 125.319 1.448 . . . . 0.0 111.444 172.745 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo . . . . . 0 CA--C 1.542 0.901 0 CA-C-O 118.748 -0.605 . . . . 0.0 111.619 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.11 172.82 6.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.39 2.727 . . . . 0.0 113.332 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.79 81.53 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.026 1.73 . . . . 0.0 113.649 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -154.08 140.01 18.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.173 1.389 . . . . 0.0 113.146 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.0 mt -128.37 12.02 6.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.44 1.896 . . . . 0.0 112.96 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.99 156.87 39.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.574 1.95 . . . . 0.0 109.992 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.6 -7.13 9.01 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.213 0 C-N-CA 125.398 1.479 . . . . 0.0 112.667 -173.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo . . . . . 0 CA--C 1.544 0.975 0 CA-C-O 119.385 -0.34 . . . . 0.0 111.379 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.88 166.74 17.45 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.447 2.765 . . . . 0.0 112.722 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 71.94 69.0 0.15 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.828 2.051 . . . . 0.0 113.471 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -146.92 40.77 1.08 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.469 1.108 . . . . 0.0 113.587 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.35 -170.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 61.1 41.98 13.01 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.92 -34.74 0.41 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.214 -0.929 . . . . 0.0 113.856 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp . . . . . 0 CA--C 1.553 1.066 0 C-N-CA 125.045 1.338 . . . . 0.0 112.472 166.962 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo . . . . . 0 CA--C 1.545 1.026 0 N-CA-C 112.927 0.318 . . . . 0.0 112.927 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.33 162.59 41.79 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.646 2.897 . . . . 0.0 113.506 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 60.59 91.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.774 2.429 . . . . 0.0 114.455 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -153.14 17.45 0.56 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.97 -162.0 0.88 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.254 1.422 . . . . 0.0 111.719 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.53 24.67 5.11 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.88 1.672 . . . . 0.0 113.606 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.09 -103.55 1.77 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.31 1.433 . . . . 0.0 112.35 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? . . . . . 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 0.0 113.59 177.694 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 CA--C 1.543 0.95 0 N-CA-C 110.794 -0.502 . . . . 0.0 110.794 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.12 170.73 17.45 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.883 2.388 . . . . 0.0 112.372 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 68.6 82.44 0.17 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.816 2.046 . . . . 0.0 112.911 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -150.93 136.73 18.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.205 1.002 . . . . 0.0 113.132 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.8 mt -142.5 10.91 1.88 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.666 1.586 . . . . 0.0 112.258 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -161.63 158.85 26.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.553 1.541 . . . . 0.0 110.466 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.62 91.45 0.29 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.92 0.771 . . . . 0.0 112.298 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt . . . . . 0 N--CA 1.481 1.086 0 C-N-CA 128.384 2.674 . . . . 0.0 113.833 178.428 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo . . . . . 0 CA--C 1.542 0.89 0 CA-C-O 119.334 -0.361 . . . . 0.0 111.821 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.92 169.15 13.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.314 2.009 . . . . 0.0 112.05 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 65.02 89.42 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.172 1.789 . . . . 0.0 113.448 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -152.87 -172.23 4.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.441 1.096 . . . . 0.0 112.742 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.482 ' H ' HD12 ' A' ' 13' ' ' LEU . 3.0 mp -71.23 -165.01 0.11 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.367 1.867 . . . . 0.0 111.589 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.82 -51.9 67.19 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.367 -1.458 . . . . 0.0 112.164 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.27 -49.4 1.23 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.489 1.995 . . . . 0.0 115.422 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.2 mttm . . . . . 0 N--CA 1.481 1.087 0 C-N-CA 129.163 2.985 . . . . 0.0 110.49 -178.217 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 CA--C 1.545 1.071 0 N-CA-C 112.979 0.338 . . . . 0.0 112.979 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.69 170.51 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.566 2.177 . . . . 0.0 112.546 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 64.51 75.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.069 1.748 . . . . 0.0 115.011 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -138.87 147.7 42.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.825 1.25 . . . . 0.0 111.963 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.74 170.98 15.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.538 1.135 . . . . 0.0 111.969 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -50.03 156.85 0.7 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.514 1.526 . . . . 0.0 114.415 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.84 -49.41 0.63 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.789 1.185 . . . . 0.0 112.953 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.965 0 C-N-CA 126.437 1.895 . . . . 0.0 109.944 176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo . . . . . 0 CA--C 1.545 1.036 0 CA-C-O 119.278 -0.384 . . . . 0.0 112.029 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.18 66.99 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 125.283 3.989 . . . . 0.0 113.253 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.28 37.72 1.9 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.332 1.853 . . . . 0.0 111.518 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.38 148.5 46.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.862 1.265 . . . . 0.0 112.283 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.34 -68.54 0.91 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.374 1.47 . . . . 0.0 109.975 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -87.39 165.93 15.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.421 1.488 . . . . 0.0 112.739 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.64 128.19 2.49 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.175 1.845 . . . . 0.0 110.624 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt . . . . . 0 CA--C 1.55 0.946 0 CA-C-N 117.931 0.865 . . . . 0.0 112.229 179.527 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo . . . . . 0 CA--C 1.543 0.959 0 CA-C-O 119.029 -0.488 . . . . 0.0 111.497 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.4 59.61 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.737 3.625 . . . . 0.0 113.364 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -137.73 46.79 2.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.531 1.933 . . . . 0.0 110.98 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -139.71 124.29 18.25 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.459 1.503 . . . . 0.0 111.518 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.75 -53.87 0.49 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.38 1.472 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.23 -37.81 7.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.05 1.34 . . . . 0.0 112.386 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.27 -10.08 56.11 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.546 0.593 . . . . 0.0 114.432 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 127.555 2.342 . . . . 0.0 111.184 179.374 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 CA--C 1.545 1.042 0 CA-C-O 119.618 -0.243 . . . . 0.0 112.326 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.47 155.26 71.04 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.555 2.837 . . . . 0.0 113.391 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 61.16 110.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.73 171.85 12.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 111.11 -173.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 13' ' ' LEU . 5.3 mp -49.85 -45.99 50.9 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.285 1.434 . . . . 0.0 114.007 -169.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.06 -59.25 4.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.405 0.682 . . . . 0.0 112.1 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.42 37.7 95.08 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 114.606 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.483 1.221 0 C-N-CA 125.753 1.621 . . . . 0.0 110.446 174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo . . . . . 0 CA--C 1.541 0.849 0 CA-C-O 119.171 -0.429 . . . . 0.0 111.789 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.3 159.94 49.96 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.126 2.55 . . . . 0.0 113.038 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 72.09 93.56 0.08 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.911 2.485 . . . . 0.0 113.588 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.94 142.65 13.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.694 1.198 . . . . 0.0 113.363 -173.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.4 -56.2 21.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.608 1.163 . . . . 0.0 112.698 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -117.27 -77.15 0.57 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.719 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.08 86.75 0.02 OUTLIER Glycine 0 C--N 1.343 0.968 0 C-N-CA 126.415 1.959 . . . . 0.0 113.99 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt . . . . . 0 N--CA 1.482 1.157 0 C-N-CA 126.259 1.824 . . . . 0.0 112.385 -171.027 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo . . . . . 0 CA--C 1.542 0.912 0 CA-C-O 118.711 -0.62 . . . . 0.0 112.268 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.43 64.57 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.787 3.658 . . . . 0.0 113.787 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -134.19 25.8 3.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.806 2.042 . . . . 0.0 112.365 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -129.42 126.07 37.94 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.978 1.311 . . . . 0.0 113.826 -173.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.1 mt -146.59 -27.36 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.763 2.025 . . . . 0.0 113.623 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -117.12 -36.99 3.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.594 1.558 . . . . 0.0 111.304 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.26 -31.11 59.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.123 0.868 . . . . 0.0 113.536 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.95 0 C-N-CA 125.507 1.523 . . . . 0.0 110.975 175.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.547 1.165 0 CA-C-O 118.649 -0.646 . . . . 0.0 112.6 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.55 58.5 2.51 Favored 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 126.933 5.089 . . . . 0.0 115.145 -169.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.65 24.46 2.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.509 1.923 . . . . 0.0 111.906 -165.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -120.52 140.23 51.76 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.809 1.644 . . . . 0.0 110.167 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.41 -71.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.767 1.227 . . . . 0.0 110.544 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -173.62 164.25 4.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.227 2.211 . . . . 0.0 109.565 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.69 132.49 3.19 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.675 1.607 . . . . 0.0 110.499 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp . . . . . 0 N--CA 1.477 0.924 0 C-N-CA 126.773 2.029 . . . . 0.0 113.701 -174.626 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.1 mm? . . . . . 0 N--CA 1.472 0.663 0 N-CA-C 109.265 -0.643 . . . . 0.0 109.265 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -92.13 123.46 35.5 Favored 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.524 0.678 . . . . 0.0 112.01 176.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -92.59 88.55 6.36 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.626 1.57 . . . . 0.0 109.942 177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 21.5 pt -141.0 155.02 68.94 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 125.418 1.487 . . . . 0.0 111.37 -174.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.4 176.52 2.65 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 123.641 2.894 . . . . 0.0 112.796 175.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -117.0 19.91 14.07 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 124.774 1.23 . . . . 0.0 112.234 177.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 15.6 t -115.34 153.51 30.85 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 128.035 2.534 . . . . 0.0 110.428 179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.467 HG22 HG21 ' A' ' 19' ' ' VAL . 8.0 tp -86.46 137.13 34.53 Favored Pre-proline 0 CA--C 1.55 0.972 0 C-N-CA 125.244 1.418 . . . . 0.0 111.614 -178.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -66.97 165.55 25.83 Favored 'Trans proline' 0 CA--C 1.545 1.029 0 C-N-CA 122.929 2.419 . . . . 0.0 111.852 170.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -65.79 178.48 2.26 Favored 'Trans proline' 0 CA--C 1.537 0.664 0 C-N-CA 122.855 2.37 . . . . 0.0 112.384 170.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 68.33 74.02 0.28 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 125.187 1.395 . . . . 0.0 112.186 175.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 33.4 p90 -142.17 133.73 26.71 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.794 1.638 . . . . 0.0 112.843 -179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -63.92 -49.55 72.18 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.485 0.714 . . . . 0.0 111.255 172.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.7 p90 -120.71 143.45 48.75 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.929 1.691 . . . . 0.0 111.164 -174.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 149.1 93.82 0.12 Allowed Glycine 0 CA--C 1.531 1.043 0 C-N-CA 124.021 0.82 . . . . 0.0 112.93 -173.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 44.3 mttp -58.68 151.63 51.34 Favored Pre-proline 0 N--CA 1.479 1.023 0 C-N-CA 123.898 0.879 . . . . 0.0 112.935 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -70.13 76.55 1.28 Allowed 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 125.153 3.902 . . . . 0.0 114.322 -173.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -121.55 18.94 11.26 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.24 1.816 . . . . 0.0 113.468 -177.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 HG22 ' A' ' 8' ' ' ILE . 15.8 m -143.36 21.47 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.211 0 C-N-CA 126.596 1.958 . . . . 0.0 113.348 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 86.9 m-85 . . . . . 0 C--O 1.251 1.18 0 O-C-N 120.327 -1.483 . . . . 0.0 110.678 -178.019 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 1.9 pt? . . . . . 0 N--CA 1.476 0.874 0 N-CA-C 113.396 0.887 . . . . 0.0 113.396 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -141.78 146.37 35.87 Favored 'General case' 0 N--CA 1.477 0.891 0 O-C-N 120.636 -1.29 . . . . 0.0 112.398 -176.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -106.38 86.37 2.34 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 125.386 1.474 . . . . 0.0 110.632 -175.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -138.93 158.94 68.92 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 126.267 1.827 . . . . 0.0 112.206 -172.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -68.7 -177.84 1.7 Allowed 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 124.338 3.359 . . . . 0.0 113.809 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.9 m -50.36 148.67 3.49 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 124.173 0.989 . . . . 0.0 112.21 168.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 12.8 m -58.44 167.85 1.29 Allowed 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 124.674 1.19 . . . . 0.0 113.122 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 23.3 mt -115.08 80.83 7.28 Favored Pre-proline 0 CA--C 1.547 0.861 0 C-N-CA 125.301 1.44 . . . . 0.0 109.324 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -69.89 165.71 30.21 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 123.967 3.111 . . . . 0.0 111.481 175.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo -66.6 165.16 26.22 Favored 'Trans proline' 0 CA--C 1.537 0.645 0 C-N-CA 123.296 2.664 . . . . 0.0 112.321 176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 76.81 73.16 0.07 Allowed 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.47 1.908 . . . . 0.0 112.258 175.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -150.18 111.6 4.44 Favored 'General case' 0 CA--C 1.546 0.797 0 O-C-N 120.883 -1.135 . . . . 0.0 113.296 -173.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.2 mp -80.7 61.45 4.38 Favored 'General case' 0 CA--C 1.545 0.767 0 C-N-CA 125.061 1.344 . . . . 0.0 111.883 177.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 85.7 m-85 -133.65 123.12 24.46 Favored 'General case' 0 N--CA 1.471 0.596 0 O-C-N 121.165 -0.959 . . . . 0.0 111.389 -177.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -117.16 27.35 7.79 Favored Glycine 0 CA--C 1.535 1.286 0 C-N-CA 126.586 2.041 . . . . 0.0 113.536 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.8 mptm? -61.37 165.29 7.13 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 125.319 1.448 . . . . 0.0 111.444 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_endo -72.37 65.13 3.64 Favored 'Trans proline' 0 CA--C 1.547 1.175 0 C-N-CA 124.481 3.454 . . . . 0.0 112.151 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -157.31 135.78 11.31 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.921 1.288 . . . . 0.0 111.513 174.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 36.0 m -147.12 176.08 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 C-N-CA 126.68 1.992 . . . . 0.0 111.612 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 4.2 p90 . . . . . 0 C--O 1.252 1.227 0 C-N-CA 125.933 1.693 . . . . 0.0 113.343 174.921 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 96.0 mt . . . . . 0 N--CA 1.48 1.039 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -134.95 131.81 37.66 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.1 0.96 . . . . 0.0 111.694 -172.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -169.31 148.3 3.87 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 126.576 1.95 . . . . 0.0 110.633 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 4.3 pt -145.49 148.46 37.22 Favored Pre-proline 0 N--CA 1.476 0.827 0 C-N-CA 123.975 0.91 . . . . 0.0 111.699 176.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -65.48 168.73 13.98 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 123.104 2.536 . . . . 0.0 111.851 175.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.6 m -56.38 158.65 4.12 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 123.8 0.84 . . . . 0.0 112.394 179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.9 t -65.5 -174.58 0.2 Allowed 'General case' 0 CA--C 1.545 0.763 0 N-CA-C 112.907 0.706 . . . . 0.0 112.907 175.078 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 55.6 mt -119.58 81.03 23.6 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 125.182 1.393 . . . . 0.0 107.565 173.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -69.02 167.03 24.65 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 124.251 3.3 . . . . 0.0 111.619 176.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -65.11 172.82 6.82 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 123.39 2.727 . . . . 0.0 113.332 177.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 64.79 81.53 0.2 Allowed 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.026 1.73 . . . . 0.0 113.649 175.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -154.08 140.01 18.22 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 125.173 1.389 . . . . 0.0 113.146 179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 25.0 mt -128.37 12.02 6.44 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 126.44 1.896 . . . . 0.0 112.96 179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -152.99 156.87 39.66 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 126.574 1.95 . . . . 0.0 109.992 -178.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 123.6 -7.13 9.01 Favored Glycine 0 CA--C 1.533 1.168 0 N-CA-C 115.854 1.102 . . . . 0.0 115.854 177.213 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 44.0 60.75 11.49 Favored Pre-proline 0 N--CA 1.483 1.213 0 C-N-CA 125.398 1.479 . . . . 0.0 112.667 -173.389 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -63.79 170.53 8.49 Favored 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 123.977 3.118 . . . . 0.0 112.249 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 35.7 p90 -137.56 21.22 2.92 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 124.39 1.076 . . . . 0.0 112.928 -173.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 30.3 m -98.53 24.52 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 C-N-CA 125.773 1.629 . . . . 0.0 112.934 -179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 . . . . . 0 C--O 1.255 1.387 0 C-N-CA 126.083 1.753 . . . . 0.0 110.845 -175.769 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 6.1 tp . . . . . 0 N--CA 1.478 0.95 0 N-CA-C 110.331 -0.248 . . . . 0.0 110.331 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -79.77 92.67 5.47 Favored 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.911 -1.118 . . . . 0.0 111.813 -178.318 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -145.24 106.88 4.24 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.254 1.022 . . . . 0.0 112.296 -176.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 8.6 pt -147.4 74.69 11.58 Favored Pre-proline 0 N--CA 1.479 1.008 0 C-N-CA 126.033 1.733 . . . . 0.0 111.107 -178.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -70.53 172.59 13.1 Favored 'Trans proline' 0 CA--C 1.538 0.688 0 C-N-CA 123.154 2.569 . . . . 0.0 112.832 179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.1 t -66.32 142.19 57.73 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 121.334 -0.854 . . . . 0.0 112.033 173.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 79.2 p -156.78 174.52 15.36 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.773 2.029 . . . . 0.0 111.523 176.34 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 56.4 mt -114.37 78.83 4.9 Favored Pre-proline 0 CA--C 1.546 0.818 0 C-N-CA 125.842 1.657 . . . . 0.0 109.411 -178.021 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_endo -66.9 160.13 48.43 Favored 'Trans proline' 0 CA--C 1.544 0.975 0 C-N-CA 122.539 2.159 . . . . 0.0 111.379 174.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -64.88 166.74 17.45 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.447 2.765 . . . . 0.0 112.722 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 71.94 69.0 0.15 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 126.828 2.051 . . . . 0.0 113.471 176.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.9 p90 -146.92 40.77 1.08 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.469 1.108 . . . . 0.0 113.587 -172.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.3 mp -102.35 -170.59 1.83 Allowed 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 125.218 1.407 . . . . 0.0 111.284 -177.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 61.1 41.98 13.01 Favored 'General case' 0 CA--C 1.545 0.764 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 172.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 160.92 -34.74 0.41 Allowed Glycine 0 N--CA 1.472 1.055 0 O-C-N 121.214 -0.929 . . . . 0.0 113.856 169.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.5 mmtp -56.67 159.83 6.4 Favored Pre-proline 0 CA--C 1.553 1.066 0 C-N-CA 125.045 1.338 . . . . 0.0 112.472 166.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -71.7 -166.2 0.24 Allowed 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.06 3.173 . . . . 0.0 112.664 176.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.2 m-85 -53.88 150.44 7.65 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 124.854 1.262 . . . . 0.0 113.313 171.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 7.1 p -147.14 140.5 19.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.662 0 C-N-CA 125.088 1.355 . . . . 0.0 112.02 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.6 m-85 . . . . . 0 C--O 1.251 1.164 0 C-N-CA 126.881 2.073 . . . . 0.0 113.723 -179.149 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 8.6 mp . . . . . 0 N--CA 1.477 0.911 0 N-CA-C 110.733 -0.099 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -94.55 179.0 5.42 Favored 'General case' 0 N--CA 1.474 0.729 0 O-C-N 120.163 -1.586 . . . . 0.0 112.015 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -73.74 117.5 15.59 Favored 'General case' 0 CA--C 1.54 0.574 0 O-C-N 121.321 -0.862 . . . . 0.0 111.419 173.129 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 15.9 pt -145.84 157.25 51.24 Favored Pre-proline 0 N--CA 1.477 0.905 0 C-N-CA 123.689 0.795 . . . . 0.0 112.739 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -70.76 176.96 6.81 Favored 'Trans proline' 0 CA--C 1.543 0.945 0 C-N-CA 124.111 3.207 . . . . 0.0 113.291 173.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.7 m -110.61 -0.13 17.36 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.32 1.448 . . . . 0.0 113.008 177.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.9 m -60.5 132.2 53.16 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 124.851 1.261 . . . . 0.0 113.295 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -58.12 152.57 40.07 Favored Pre-proline 0 CA--C 1.549 0.913 0 C-N-CA 125.294 1.438 . . . . 0.0 113.102 177.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -69.17 169.03 19.1 Favored 'Trans proline' 0 CA--C 1.545 1.026 0 C-N-CA 123.777 2.985 . . . . 0.0 112.927 175.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 62.2 Cg_endo -70.33 162.59 41.79 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.646 2.897 . . . . 0.0 113.506 173.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 42.8 mm-40 60.59 91.06 0.06 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 127.774 2.429 . . . . 0.0 114.455 -178.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -153.14 17.45 0.56 Allowed 'General case' 0 CA--C 1.548 0.898 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 -172.121 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -160.97 -162.0 0.88 Allowed 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 125.254 1.422 . . . . 0.0 111.719 177.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 2.6 p90 -130.53 24.67 5.11 Favored 'General case' 0 CA--C 1.552 1.058 0 C-N-CA 125.88 1.672 . . . . 0.0 113.606 177.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -122.09 -103.55 1.77 Allowed Glycine 0 CA--C 1.532 1.152 0 C-N-CA 125.31 1.433 . . . . 0.0 112.35 -174.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.3 mmmp? 58.58 67.27 2.16 Favored Pre-proline 0 N--CA 1.48 1.054 0 C-N-CA 125.436 1.494 . . . . 0.0 113.59 177.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -72.74 77.06 2.31 Favored 'Trans proline' 0 CA--C 1.546 1.102 0 C-N-CA 125.211 3.941 . . . . 0.0 112.813 -178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 49.79 34.97 8.25 Favored 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 125.46 1.504 . . . . 0.0 114.966 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 6.6 m -93.06 0.88 9.66 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 C-N-CA 125.827 1.651 . . . . 0.0 114.152 -178.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 . . . . . 0 C--O 1.252 1.23 0 C-N-CA 126.094 1.758 . . . . 0.0 111.434 -175.938 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 50.0 mt . . . . . 0 N--CA 1.485 1.296 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 53.1 mt-10 44.56 41.24 4.61 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 125.446 1.499 . . . . 0.0 113.564 -174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -136.37 110.3 8.21 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.914 2.086 . . . . 0.0 109.414 -172.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.1 pp -150.3 160.92 32.22 Favored Pre-proline 0 CA--C 1.549 0.915 0 C-N-CA 127.245 2.218 . . . . 0.0 109.8 -174.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -76.25 -177.78 3.94 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 123.471 2.78 . . . . 0.0 112.325 174.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 61.8 m 55.64 60.7 3.18 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 125.124 1.37 . . . . 0.0 113.008 176.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 19.7 t -56.39 132.22 50.5 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.714 0.806 . . . . 0.0 111.612 -177.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 30.7 mm -114.79 77.98 4.98 Favored Pre-proline 0 CA--C 1.544 0.73 0 C-N-CA 125.394 1.478 . . . . 0.0 108.377 173.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -69.23 162.75 40.55 Favored 'Trans proline' 0 CA--C 1.543 0.95 0 C-N-CA 122.578 2.185 . . . . 0.0 110.794 170.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 90.1 Cg_endo -71.12 170.73 17.45 Favored 'Trans proline' 0 CA--C 1.538 0.697 0 C-N-CA 122.883 2.388 . . . . 0.0 112.372 178.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 68.6 82.44 0.17 Allowed 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.816 2.046 . . . . 0.0 112.911 177.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 27.1 p90 -150.93 136.73 18.1 Favored 'General case' 0 N--CA 1.467 0.382 0 C-N-CA 124.205 1.002 . . . . 0.0 113.132 -177.243 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.8 mt -142.5 10.91 1.88 Allowed 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.666 1.586 . . . . 0.0 112.258 -177.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -161.63 158.85 26.76 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 125.553 1.541 . . . . 0.0 110.466 -175.808 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 77.62 91.45 0.29 Allowed Glycine 0 CA--C 1.531 1.088 0 C-N-CA 123.92 0.771 . . . . 0.0 112.298 -176.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 71.9 mmtt 76.97 154.15 0.14 Allowed Pre-proline 0 N--CA 1.481 1.086 0 C-N-CA 128.384 2.674 . . . . 0.0 113.833 178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -66.33 173.0 8.12 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 123.643 2.895 . . . . 0.0 112.214 174.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.4 p90 -53.13 151.16 5.18 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 29.1 m -133.11 41.63 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.989 0 C-N-CA 126.124 1.77 . . . . 0.0 111.702 -172.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 83.6 m-85 . . . . . 0 C--O 1.25 1.091 0 C-N-CA 126.269 1.828 . . . . 0.0 112.191 -172.741 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 5.4 tt . . . . . 0 N--CA 1.479 0.998 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -89.09 134.32 34.05 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 124.739 1.216 . . . . 0.0 111.969 -178.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -127.23 87.5 2.65 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 125.407 1.483 . . . . 0.0 111.852 -167.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 44.4 mm -101.46 136.94 19.52 Favored Pre-proline 0 CA--C 1.545 0.77 0 C-N-CA 125.657 1.583 . . . . 0.0 109.498 -172.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -70.49 179.66 3.93 Favored 'Trans proline' 0 CA--C 1.54 0.822 0 C-N-CA 124.204 3.269 . . . . 0.0 112.674 177.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 6.6 t -154.72 147.19 24.04 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.393 0.677 . . . . 0.0 111.814 167.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.1 m -111.53 156.65 21.41 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.24 1.416 . . . . 0.0 110.367 174.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 22.7 pt -55.8 149.88 30.23 Favored Pre-proline 0 CA--C 1.546 0.805 0 C-N-CA 123.662 0.785 . . . . 0.0 112.229 174.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -61.92 162.83 20.98 Favored 'Trans proline' 0 CA--C 1.542 0.89 0 C-N-CA 122.657 2.238 . . . . 0.0 111.821 174.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -65.92 169.15 13.81 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.314 2.009 . . . . 0.0 112.05 176.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 45.2 mm-40 65.02 89.42 0.1 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 126.172 1.789 . . . . 0.0 113.448 177.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 34.0 p90 -152.87 -172.23 4.18 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.441 1.096 . . . . 0.0 112.742 -175.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.482 ' H ' HD12 ' A' ' 13' ' ' LEU . 3.0 mp -71.23 -165.01 0.11 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 126.367 1.867 . . . . 0.0 111.589 177.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 22.0 m-85 -56.82 -51.9 67.19 Favored 'General case' 0 CA--C 1.543 0.685 0 O-C-N 120.367 -1.458 . . . . 0.0 112.164 174.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 72.27 -49.4 1.23 Allowed Glycine 0 CA--C 1.537 1.462 0 C-N-CA 126.489 1.995 . . . . 0.0 115.422 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.2 mttm -158.33 163.72 23.52 Favored Pre-proline 0 N--CA 1.481 1.087 0 C-N-CA 129.163 2.985 . . . . 0.0 110.49 -178.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -69.52 -163.03 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 124.863 3.709 . . . . 0.0 113.003 178.393 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -58.49 96.27 0.03 OUTLIER 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 125.31 1.444 . . . . 0.0 112.845 174.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 26.7 m -141.65 17.88 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.226 0 C-N-CA 126.144 1.778 . . . . 0.0 112.754 -176.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.8 m-85 . . . . . 0 C--O 1.253 1.264 0 C-N-CA 126.01 1.724 . . . . 0.0 109.285 179.829 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.2 mm? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mm-40 48.08 37.61 8.23 Favored 'General case' 0 CA--C 1.553 1.065 0 C-N-CA 125.598 1.559 . . . . 0.0 112.784 -177.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -123.94 92.27 3.64 Favored 'General case' 0 N--CA 1.473 0.695 0 O-C-N 119.896 -1.752 . . . . 0.0 111.411 -172.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.54 162.51 41.6 Favored Pre-proline 0 CA--C 1.547 0.846 0 C-N-CA 127.123 2.169 . . . . 0.0 111.625 -175.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 99.0 Cg_endo -76.5 -20.48 13.96 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 123.383 2.722 . . . . 0.0 113.67 175.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 57.0 m -58.7 162.27 4.1 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.869 1.267 . . . . 0.0 112.746 176.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 16.2 m -137.58 131.74 32.08 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 124.143 0.977 . . . . 0.0 110.877 173.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -62.01 157.24 52.98 Favored Pre-proline 0 CA--C 1.552 1.02 0 C-N-CA 124.708 1.203 . . . . 0.0 112.472 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -66.71 169.03 15.31 Favored 'Trans proline' 0 CA--C 1.545 1.071 0 C-N-CA 123.64 2.894 . . . . 0.0 112.979 173.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -68.69 170.51 15.08 Favored 'Trans proline' 0 CA--C 1.542 0.889 0 C-N-CA 122.566 2.177 . . . . 0.0 112.546 173.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 64.51 75.8 0.36 Allowed 'General case' 0 N--CA 1.476 0.838 0 C-N-CA 126.069 1.748 . . . . 0.0 115.011 174.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 26.2 p90 -138.87 147.7 42.73 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.825 1.25 . . . . 0.0 111.963 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 68.6 mt -75.74 170.98 15.15 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 124.538 1.135 . . . . 0.0 111.969 178.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -50.03 156.85 0.7 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 125.514 1.526 . . . . 0.0 114.415 173.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 146.84 -49.41 0.63 Allowed Glycine 0 CA--C 1.533 1.168 0 C-N-CA 124.789 1.185 . . . . 0.0 112.953 177.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.25 73.32 37.51 Favored Pre-proline 0 N--CA 1.478 0.965 0 C-N-CA 126.437 1.895 . . . . 0.0 109.944 176.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -76.19 146.62 28.73 Favored 'Trans proline' 0 CA--C 1.54 0.783 0 C-N-CA 123.084 2.523 . . . . 0.0 111.432 173.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -134.76 115.47 13.76 Favored 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 125.347 1.459 . . . . 0.0 109.955 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 3.2 t 50.77 50.88 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.868 0 C-N-CA 125.068 1.347 . . . . 0.0 112.202 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 20.0 m-85 . . . . . 0 C--O 1.256 1.415 0 CA-C-O 116.354 -1.784 . . . . 0.0 113.474 -175.241 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 69.9 mt . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 112.857 0.688 . . . . 0.0 112.857 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -77.14 93.34 3.9 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 125.298 1.439 . . . . 0.0 113.263 -172.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -82.41 67.99 8.67 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 125.289 1.435 . . . . 0.0 113.188 -178.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.4 pp -141.46 163.2 42.91 Favored Pre-proline 0 N--CA 1.474 0.753 0 C-N-CA 126.615 1.966 . . . . 0.0 111.355 -178.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 69.8 Cg_endo -76.76 -51.42 0.09 OUTLIER 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 122.264 1.976 . . . . 0.0 112.092 173.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 p -89.9 110.18 21.15 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.268 1.427 . . . . 0.0 111.921 -173.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.5 t -67.28 174.98 2.9 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.993 1.317 . . . . 0.0 112.564 178.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mm 61.25 68.22 1.26 Allowed Pre-proline 0 CA--C 1.553 1.072 0 C-N-CA 125.586 1.554 . . . . 0.0 111.463 -168.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -67.21 165.08 27.87 Favored 'Trans proline' 0 CA--C 1.545 1.036 0 C-N-CA 123.619 2.879 . . . . 0.0 112.029 176.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -72.18 66.99 3.44 Favored 'Trans proline' 0 CA--C 1.545 1.056 0 C-N-CA 125.283 3.989 . . . . 0.0 113.253 -176.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -140.28 37.72 1.9 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 126.332 1.853 . . . . 0.0 111.518 -171.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 36.4 p90 -137.38 148.5 46.26 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.862 1.265 . . . . 0.0 112.283 -178.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 66.1 mt -116.34 -68.54 0.91 Allowed 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 125.374 1.47 . . . . 0.0 109.975 177.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 29.5 p90 -87.39 165.93 15.22 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 125.421 1.488 . . . . 0.0 112.739 178.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 139.64 128.19 2.49 Favored Glycine 0 CA--C 1.528 0.858 0 C-N-CA 126.175 1.845 . . . . 0.0 110.624 173.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.7 mptt -60.8 156.01 48.64 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-N 117.931 0.865 . . . . 0.0 112.229 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.26 88.87 0.39 Allowed 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 124.032 3.155 . . . . 0.0 112.711 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -136.79 16.12 3.09 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 126.776 2.03 . . . . 0.0 112.773 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.8 m -139.95 -177.79 1.51 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.118 0 C-N-CA 126.026 1.73 . . . . 0.0 111.128 -177.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 29.8 p90 . . . . . 0 C--O 1.252 1.227 0 N-CA-C 115.397 1.629 . . . . 0.0 115.397 178.64 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 40.7 mt . . . . . 0 N--CA 1.471 0.585 0 N-CA-C 109.23 -0.656 . . . . 0.0 109.23 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 53.31 20.88 2.08 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.392 1.477 . . . . 0.0 114.773 -176.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -84.45 67.98 10.1 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.968 1.707 . . . . 0.0 111.328 -173.836 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 1.3 pp -141.26 160.57 56.98 Favored Pre-proline 0 CA--C 1.549 0.94 0 C-N-CA 126.165 1.786 . . . . 0.0 111.897 -179.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -67.53 -172.03 0.35 Allowed 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 124.276 3.318 . . . . 0.0 112.65 173.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.5 p -60.44 -178.58 0.09 Allowed 'General case' 0 CA--C 1.55 0.977 0 O-C-N 121.39 -0.819 . . . . 0.0 113.0 168.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 38.1 t -47.43 142.48 4.16 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 124.359 1.064 . . . . 0.0 113.512 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 mt -111.47 74.94 1.22 Allowed Pre-proline 0 CA--C 1.547 0.856 0 C-N-CA 125.609 1.564 . . . . 0.0 108.962 177.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.05 168.57 17.01 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 123.231 2.621 . . . . 0.0 111.497 174.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -70.4 59.61 1.96 Allowed 'Trans proline' 0 CA--C 1.546 1.119 0 C-N-CA 124.737 3.625 . . . . 0.0 113.364 177.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -137.73 46.79 2.08 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.531 1.933 . . . . 0.0 110.98 -175.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -139.71 124.29 18.25 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 125.459 1.503 . . . . 0.0 111.518 178.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 5.4 mp -140.75 -53.87 0.49 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.38 1.472 . . . . 0.0 111.409 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 84.9 m-85 -102.23 -37.81 7.94 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 125.05 1.34 . . . . 0.0 112.386 -177.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -67.27 -10.08 56.11 Favored Glycine 0 CA--C 1.536 1.378 0 C-N-CA 123.546 0.593 . . . . 0.0 114.432 176.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 25.2 mmtp -123.99 163.1 37.51 Favored Pre-proline 0 N--CA 1.477 0.899 0 C-N-CA 127.555 2.342 . . . . 0.0 111.184 179.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -66.48 -173.42 0.36 Allowed 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.522 2.815 . . . . 0.0 112.439 173.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.3 m-85 -49.3 123.37 7.34 Favored 'General case' 0 N--CA 1.469 0.52 0 C-N-CA 124.23 1.012 . . . . 0.0 111.603 172.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 34.7 m -63.11 147.0 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 CA-C-O 121.071 0.462 . . . . 0.0 111.625 -176.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.4 p90 . . . . . 0 C--O 1.259 1.558 0 C-N-CA 124.929 1.292 . . . . 0.0 113.951 178.373 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 4.5 mm? . . . . . 0 N--CA 1.468 0.439 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 8.5 mp0 -94.27 150.77 19.98 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 123.852 0.861 . . . . 0.0 110.894 178.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -139.19 126.26 21.16 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.923 1.289 . . . . 0.0 110.556 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.526 HG22 ' H ' ' A' ' 6' ' ' CYS . 4.0 mp -108.61 130.02 23.26 Favored Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 124.675 1.19 . . . . 0.0 108.156 -175.237 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.91 -13.44 38.42 Favored 'Trans proline' 0 CA--C 1.54 0.782 0 C-N-CA 122.261 1.974 . . . . 0.0 113.298 176.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.526 ' H ' HG22 ' A' ' 4' ' ' ILE . 0.5 OUTLIER -95.01 4.63 53.58 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 125.683 1.593 . . . . 0.0 114.374 -178.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 61.4 m -46.93 141.41 4.1 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 124.226 1.01 . . . . 0.0 112.998 178.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.8 mt 62.71 79.64 0.26 Allowed Pre-proline 0 CA--C 1.551 1.018 0 C-N-CA 124.867 1.267 . . . . 0.0 110.286 -170.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -67.89 162.37 39.98 Favored 'Trans proline' 0 CA--C 1.545 1.042 0 C-N-CA 124.079 3.186 . . . . 0.0 112.326 174.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -67.47 155.26 71.04 Favored 'Trans proline' 0 CA--C 1.539 0.73 0 C-N-CA 123.555 2.837 . . . . 0.0 113.391 179.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 57.3 mt-10 61.16 110.56 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.8 0 C-N-CA 127.516 2.326 . . . . 0.0 112.938 -172.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 22.9 p90 -165.73 171.85 12.46 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.092 1.357 . . . . 0.0 111.11 -173.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.596 ' H ' HD12 ' A' ' 13' ' ' LEU . 5.3 mp -49.85 -45.99 50.9 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.285 1.434 . . . . 0.0 114.007 -169.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 97.9 m-85 -65.06 -59.25 4.34 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.405 0.682 . . . . 0.0 112.1 177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 62.42 37.7 95.08 Favored Glycine 0 CA--C 1.538 1.497 0 O-C-N 121.32 -0.862 . . . . 0.0 114.606 -176.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -111.97 75.72 1.6 Allowed Pre-proline 0 N--CA 1.483 1.221 0 C-N-CA 125.753 1.621 . . . . 0.0 110.446 174.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.9 Cg_endo -76.9 75.78 4.39 Favored 'Trans proline' 0 CA--C 1.545 1.034 0 C-N-CA 123.979 3.119 . . . . 0.0 111.66 179.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -133.06 10.64 4.21 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.46 1.504 . . . . 0.0 113.442 -176.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 15.5 m -144.56 44.88 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 C-N-CA 126.945 2.098 . . . . 0.0 111.97 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 . . . . . 0 C--O 1.267 2.005 0 C-N-CA 126.375 1.87 . . . . 0.0 112.601 -173.715 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . 0.41 HD13 ' HA ' ' A' ' 1' ' ' LEU . 4.5 mm? . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -135.75 157.82 45.92 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.135 1.374 . . . . 0.0 111.195 -174.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -98.76 108.79 21.57 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 124.037 0.935 . . . . 0.0 111.213 -179.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 37.1 mt 64.64 128.76 0.03 OUTLIER Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 128.314 2.646 . . . . 0.0 112.94 -178.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -63.18 -51.29 2.85 Favored 'Trans proline' 0 C--N 1.354 0.833 0 C-N-CA 122.742 2.295 . . . . 0.0 111.245 176.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 53.7 m -57.92 123.67 16.6 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.529 1.132 . . . . 0.0 111.167 172.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 50.4 m -113.3 16.5 19.01 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.521 1.128 . . . . 0.0 113.09 179.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -142.45 157.44 62.61 Favored Pre-proline 0 CA--C 1.545 0.773 0 C-N-CA 126.954 2.102 . . . . 0.0 111.362 -176.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -68.76 163.18 38.22 Favored 'Trans proline' 0 CA--C 1.541 0.849 0 C-N-CA 123.216 2.611 . . . . 0.0 111.789 175.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -67.3 159.94 49.96 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.126 2.55 . . . . 0.0 113.038 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 72.09 93.56 0.08 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 127.911 2.485 . . . . 0.0 113.588 175.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 20.2 p90 -159.94 142.65 13.61 Favored 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 124.694 1.198 . . . . 0.0 113.363 -173.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -54.4 -56.2 21.03 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 124.608 1.163 . . . . 0.0 112.698 -177.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -117.27 -77.15 0.57 Allowed 'General case' 0 N--CA 1.467 0.417 0 C-N-CA 124.798 1.239 . . . . 0.0 110.719 -178.56 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 54.08 86.75 0.02 OUTLIER Glycine 0 C--N 1.343 0.968 0 C-N-CA 126.415 1.959 . . . . 0.0 113.99 173.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt 61.67 171.73 0.07 OUTLIER Pre-proline 0 N--CA 1.482 1.157 0 C-N-CA 126.259 1.824 . . . . 0.0 112.385 -171.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -71.07 -163.29 0.12 Allowed 'Trans proline' 0 CA--C 1.548 1.193 0 C-N-CA 122.791 2.327 . . . . 0.0 111.921 171.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -55.12 -19.86 8.57 Favored 'General case' 0 CA--C 1.548 0.887 0 N-CA-C 114.557 1.318 . . . . 0.0 114.557 175.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 22.1 m -137.74 -179.51 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 127.002 2.121 . . . . 0.0 110.491 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 . . . . . 0 C--O 1.256 1.432 0 C-N-CA 125.06 1.344 . . . . 0.0 109.7 178.839 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 67.9 mt . . . . . 0 N--CA 1.485 1.304 0 CA-C-O 120.977 0.417 . . . . 0.0 110.848 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 48.7 mt-10 -90.91 59.18 4.03 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 120.788 -1.195 . . . . 0.0 112.538 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -132.96 101.33 5.2 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 121.11 -0.994 . . . . 0.0 111.573 -178.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 13.7 pt -146.08 153.73 49.57 Favored Pre-proline 0 N--CA 1.475 0.821 0 C-N-CA 125.37 1.468 . . . . 0.0 112.809 -175.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -79.08 -24.03 7.19 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 124.039 3.16 . . . . 0.0 113.658 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 78.4 m -64.81 118.05 8.43 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 118.561 0.619 . . . . 0.0 109.92 172.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 53.7 m -83.81 179.47 7.56 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 125.142 1.377 . . . . 0.0 110.378 174.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.7 mm 52.31 69.33 2.47 Favored Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.63 1.172 . . . . 0.0 111.91 177.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.5 162.49 41.72 Favored 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.056 3.171 . . . . 0.0 112.268 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 96.4 Cg_endo -71.43 64.57 2.88 Favored 'Trans proline' 0 CA--C 1.547 1.143 0 C-N-CA 124.787 3.658 . . . . 0.0 113.787 -176.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -134.19 25.8 3.86 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.806 2.042 . . . . 0.0 112.365 -172.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.8 p90 -129.42 126.07 37.94 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.978 1.311 . . . . 0.0 113.826 -173.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 20.1 mt -146.59 -27.36 0.41 Allowed 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 126.763 2.025 . . . . 0.0 113.623 -173.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 92.8 m-85 -117.12 -36.99 3.64 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 125.594 1.558 . . . . 0.0 111.304 -178.289 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -74.26 -31.11 59.74 Favored Glycine 0 CA--C 1.533 1.203 0 C-N-CA 124.123 0.868 . . . . 0.0 113.536 173.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.98 77.75 71.06 Favored Pre-proline 0 N--CA 1.478 0.95 0 C-N-CA 125.507 1.523 . . . . 0.0 110.975 175.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -73.44 177.52 7.83 Favored 'Trans proline' 0 CA--C 1.543 0.959 0 C-N-CA 124.017 3.144 . . . . 0.0 111.703 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 57.1 64.47 1.62 Allowed 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 125.189 1.395 . . . . 0.0 113.563 178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -153.95 -178.02 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.982 0 C-N-CA 124.163 0.985 . . . . 0.0 112.771 -174.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.0 p90 . . . . . 0 C--O 1.256 1.42 0 C-N-CA 127.846 2.458 . . . . 0.0 116.611 177.18 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LEU . . . . . . . . . . . . . 7.1 mp . . . . . 0 N--CA 1.477 0.902 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 -77.57 58.31 1.74 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.418 1.487 . . . . 0.0 112.846 -178.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ALA . . . . . . . . . . . . . . . -144.2 130.4 19.67 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.407 1.083 . . . . 0.0 111.558 179.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.93 152.6 62.52 Favored Pre-proline 0 N--CA 1.469 0.514 0 C-N-CA 126.154 1.781 . . . . 0.0 110.129 -174.171 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PRO . . . . . . . . . . . . . 57.4 Cg_endo -69.1 -32.65 20.86 Favored 'Trans proline' 0 CA--C 1.537 0.65 0 C-N-CA 122.493 2.129 . . . . 0.0 112.279 -179.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 30.5 p -76.91 169.08 18.98 Favored 'General case' 0 CA--C 1.543 0.7 0 C-N-CA 125.621 1.568 . . . . 0.0 114.07 -178.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.0 t -102.24 41.11 1.25 Allowed 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.978 1.311 . . . . 0.0 112.921 -173.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 25.5 mm 56.29 67.02 3.01 Favored Pre-proline 0 N--CA 1.482 1.15 0 C-N-CA 125.331 1.452 . . . . 0.0 112.112 -173.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -66.7 160.12 47.89 Favored 'Trans proline' 0 CA--C 1.547 1.165 0 C-N-CA 123.963 3.109 . . . . 0.0 112.6 -179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_endo -71.55 58.5 2.51 Favored 'Trans proline' 0 CA--C 1.547 1.132 1 C-N-CA 126.933 5.089 . . . . 0.0 115.145 -169.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLU . . . . . . . . . . . . . 59.0 mt-10 -139.65 24.46 2.43 Favored 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 126.509 1.923 . . . . 0.0 111.906 -165.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PHE . . . . . . . . . . . . . 42.4 p90 -120.52 140.23 51.76 Favored 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.809 1.644 . . . . 0.0 110.167 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -78.41 -71.88 0.41 Allowed 'General case' 0 N--CA 1.468 0.432 0 C-N-CA 124.767 1.227 . . . . 0.0 110.544 -176.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -173.62 164.25 4.42 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 127.227 2.211 . . . . 0.0 109.565 -177.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 134.69 132.49 3.19 Favored Glycine 0 CA--C 1.527 0.79 0 C-N-CA 125.675 1.607 . . . . 0.0 110.499 177.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 26.7 tptp 30.68 69.27 0.69 Allowed Pre-proline 0 N--CA 1.477 0.924 0 C-N-CA 126.773 2.029 . . . . 0.0 113.701 -174.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -69.66 89.56 0.51 Allowed 'Trans proline' 0 CA--C 1.538 0.687 0 C-N-CA 123.635 2.89 . . . . 0.0 111.35 -173.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -120.23 23.92 10.69 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 125.871 1.668 . . . . 0.0 112.085 -177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.92 -178.54 2.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 C-N-CA 128.072 2.549 . . . . 0.0 109.12 177.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 49.6 p90 . . . . . 0 C--O 1.252 1.199 0 C-N-CA 126.473 1.909 . . . . 0.0 115.622 179.24 . . . . . . . . 0 0 . 1 stop_ save_